<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Yale J Biol Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Yale J Biol Med</journal-id>
<journal-id journal-id-type="pmc">yjbm</journal-id>
<journal-id journal-id-type="publisher-id">YJBM</journal-id>
<journal-title-group>
<journal-title>The Yale Journal of Biology and Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">0044-0086</issn>
<issn pub-type="epub">1551-4056</issn>
<publisher>
<publisher-name>YJBM</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28018138</article-id>
<article-id pub-id-type="pmc">5168825</article-id>
<article-id pub-id-type="publisher-id">yjbm894457</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
<series-title>Focus: Epigenetics</series-title>
</article-categories>
<title-group>
<article-title>Editing the Neuronal Genome: a CRISPR View of Chromatin Regulation in Neuronal Development, Function, and Plasticity</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Marty G.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>West</surname>
<given-names>Anne E.</given-names>
</name>
<xref ref-type="corresp" rid="COR1">*</xref>
</contrib>
<aff>Department of Neurobiology, Duke University, Durham, NC</aff>
</contrib-group>
<author-notes>
<corresp id="COR1"><label>*</label>Anne West, Department of Neurobiology, DUMC Box 3209, 311 Research Drive, Bryan Research 301D, Durham, NC 27710, Phone: 919-681-1909, Fax: 919-668-4431, <email>west@neuro.duke.edu</email>.</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>23</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<month>12</month>
<year>2016</year>
</pub-date>
<volume>89</volume>
<issue>4</issue>
<fpage>457</fpage>
<lpage>470</lpage>
<permissions>
<copyright-statement>Copyright ©2016, Yale Journal of Biology and
Medicine</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>Yale Journal of Biology and Medicine</copyright-holder>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc/3.0/">
<license-p>This is an open access article distributed under the terms of the Creative Commons CC BY-NC license, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use the material for commercial purposes.</license-p>
</license>
</permissions>
<abstract>
<p>The dynamic orchestration of gene expression is crucial for the proper differentiation, function, and adaptation of cells. In the brain, transcriptional regulation underlies the incredible diversity of neuronal cell types and contributes to the ability of neurons to adapt their function to the environment. Recently, novel methods for genome and epigenome editing have begun to revolutionize our understanding of gene regulatory mechanisms. In particular, the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system has proven to be a particularly accessible and adaptable technique for genome engineering. Here, we review the use of CRISPR/Cas9 in neurobiology and discuss how these studies have advanced understanding of nervous system development and plasticity. We cover four especially salient applications of CRISPR/Cas9: testing the consequences of enhancer mutations, tagging genes and gene products for visualization in live cells, directly activating or repressing enhancers <italic>in vivo</italic>, and manipulating the epigenome. In each case, we summarize findings from recent studies and discuss evolving adaptations of the method.</p>
</abstract>
<kwd-group>
<kwd>CRISPR/Cas9</kwd>
<kwd>genome editing</kwd>
<kwd>neuron</kwd>
<kwd>chromatin</kwd>
<kwd>enhancer</kwd>
<kwd>transcription</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>The brain presents an ideal frontier into which to deploy the remarkable technical advances in genome biology that emerged from the completion of the Human Genome Project. Although the incredible diversity of cell types in the mammalian brain share a single genomic blueprint, they express highly distinct transcriptional profiles, which neurobiologists have begun to characterize at the single-cell level using the emergence of increasingly sensitive next-generation sequencing technologies. Furthermore, even once they are fully differentiated, neurons experience large-scale dynamic waves of new gene transcription in response to environmental exposures. The evidence that these transcriptional states can be mediated by activity-dependent regulation of chromatin modifying enzymes has driven an explosion in the field of neuroepigenetics [<xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R2">2</xref>]. This field addresses the tempting hypothesis that upon neuronal activity, biochemical mechanisms of chromatin regulation [<xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R4">4</xref>] can shift transcriptional output when neuronal circuits are subsequently reactivated. Our goal in this review is to show how the combination of sequencing data with the emerging genome and epigenome editing strategies made easily possible using <underline>c</underline>lustered <underline>r</underline>egularly <underline>i</underline>nterspaced <underline>s</underline>hort <underline>p</underline>alindromic <underline>r</underline>epeats (CRISPR)/Cas9 technology has enabled rapid discoveries that reveal how cooperation between coding and non-coding elements of the genome both establish and adapt neuronal transcriptional programs and brain function.</p>
</sec>
<sec id="s2" sec-type="discussion">
<title>Functional Relevance of Gene Regulation in the Nervous System</title>
<p><italic>How is the diversity of neuronal cell types established during development?</italic> We are only just beginning to understand how different gene expression programs are progressively regulated over the course of development as precursor cells divide, differentiate, and commit to distinct fates [<xref ref-type="bibr" rid="R5">5</xref>]. For each gene in the mammalian genome, there exists a cohort of non-coding <italic>cis</italic>-regulatory elements that enable precise spatiotemporal control over its expression [<xref ref-type="bibr" rid="R6">6</xref>,<xref ref-type="bibr" rid="R7">7</xref>] (<xref ref-type="fig" rid="F1">Figure 1</xref>). Among these gene regulatory regions, proximal promoters are the best characterized due to their proximity to their target genes. Less is known about the specific functions and regulatory logic of distal regulatory elements, which include the distal enhancers that activate gene expression, as well as insulators that serve to buffer interactions between enhancers and promoters. Improvements in our understanding of the chromatin signatures that mark these gene regulatory elements [<xref ref-type="bibr" rid="R8">8</xref>] have enabled genome-wide identification of putative neuronal <italic>cis</italic>-regulatory elements [<xref ref-type="bibr" rid="R9">9</xref>]. However, it remains an ongoing challenge to experimentally test the functional importance of neuronal enhancers in their native genomic context. Existing enhancer reporter assays [<xref ref-type="bibr" rid="R10">10</xref>], including lacZ, GFP, and luciferase reporter plasmids, can provide convenient readouts for enhancer activity, but they fail to recapitulate the enhancer’s role in its native genomic context and cannot reveal the specific genes regulated by any given distal element. In contrast, as we discuss below, application of genome editing technologies is beginning to massively accelerate functional annotation of neuronal <italic>cis</italic>-regulatory elements within the mammalian genome.</p>
<p><italic>How does the environment intersect with the genome to guide activity-dependent brain development?</italic> Although each neuron, like all other cells in the body, has a genetic code that provides a blueprint for its development and mature function, the brain is unique in the extreme to which it integrates and responds transcriptionally to a dynamic and diverse set of extrinsic stimuli. Just like in non-neuronal cell types, unique combinations of transcription factors binding to distinct <italic>cis</italic>-regulatory elements determine the expression of lineage-specific transcriptional programs and ultimately define cellular identities in the central nervous system [<xref ref-type="bibr" rid="R11">11</xref>]. However, in addition to these intrinsically defined programs of gene expression, sensory experience during postnatal neural development is capable of eliciting persistent, long-term changes to neuronal structure and function, many of which require the transcription of gene products in an activity-regulated manner that converge from complex signaling pathways [<xref ref-type="bibr" rid="R12">12</xref>]. Such neuronal activity-dependent gene expression programs and their regulation have been extensively studied [<xref ref-type="bibr" rid="R13">13</xref>,<xref ref-type="bibr" rid="R14">14</xref>]. Activity-regulated transcriptional programs are critical for neuronal plasticity because they are fundamentally situated at the interface between the intrinsic genome and the extrinsic environment. The availability of genetic approaches to manipulate specific cellular and progenitor populations in the brain, as well as the technology to interrogate genomic changes with single-cell resolution, makes this an exciting era to apply genome editing technologies to study the genome-environment interactions that define brain development and function.</p>
<p><italic>What is the function of epigenetic regulation in neural plasticity?</italic> It is well known that the epigenetic landscape of the genome can influence gene expression in other cell types [<xref ref-type="bibr" rid="R15">15</xref>] and it is now better appreciated that the neuronal epigenome imparts dynamic changes that enable specific genes to be activated or repressed with temporal and spatial specificity [<xref ref-type="bibr" rid="R16">16</xref>]. This led to the start of the field of neuroepigenetics, which addresses how biochemical features laid on top of the DNA code modulate features of neuronal gene expression and function. These include the biophysical conformation of chromatin, the post-translational modifications of histone proteins that wrap around DNA, and the biochemical alterations to DNA nucleotides. Due to the inducible and often persistent nature of these epigenetic marks [<xref ref-type="bibr" rid="R4">4</xref>], it has been suggested that these epigenomic modifications contribute to the ability of a neuron to retain information from prior stimuli to influence how that neuron initiates transcriptional responses to future stimuli. However, it has been challenging to directly test the hypothesis that site-specific epigenomic modifications are actually causative for the neural plasticities that underlie functionally interesting processes in the brain like learning and memory [<xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R2">2</xref>]. The continued growth of genome editing technologies has expanded in the realm of the epigenome and there now exist methods to probe how each of these epigenomic components regulate transcription and neuronal function in the mammalian brain.</p>
</sec>
<sec id="s3" sec-type="discussion">
<title>The Genome Engineering Revolution: Why CRISPR is Better</title>
<p><italic>How can protein complexes be recruited to a single site in the genome?</italic> Protein engineers recognized the capacity of endogenous transcription factors to design synthetic proteins that target specific sites in the genome. The first such tool fused the DNA binding domain of two different zinc-finger transcription factors to the enzymatic domain of the FokI restriction enzyme [<xref ref-type="bibr" rid="R17">17</xref>], demonstrating DNA cleavage in a sequence-specific manner. Cys<sub>2</sub>-His<sub>2</sub> zinc finger domains are about 30bp long and are among the most ubiquitous DNA-binding domains present in transcription factors [<xref ref-type="bibr" rid="R18">18</xref>-<xref ref-type="bibr" rid="R20">20</xref>]. By linking multiple zinc fingers together in tandem arrays, it is technically possible to design a synthetic protein that can recognize any given DNA sequence, forming the basis of zinc finger nuclease (ZFN) technology that propelled the modern era of genome editing [<xref ref-type="bibr" rid="R21">21</xref>]. Similarly, the <underline>t</underline>ranscription <underline>a</underline>ctivator-like <underline>e</underline>ffector <underline>n</underline>ucleases (TALENs) are a natural form of DNA-binding proteins produced by plant pathogens that can be stitched together in different permutations to recognize unique DNA sequences [<xref ref-type="bibr" rid="R22">22</xref>,<xref ref-type="bibr" rid="R23">23</xref>].</p>
<p>ZFN and TALEN technologies offer what genome engineers want most: high precision, sequence-specific DNA binding coupled with a modular architecture to pair with different effector domains. However, they come at a significant financial and technical cost out of range for most laboratories [<xref ref-type="bibr" rid="R24">24</xref>], a likely reason the simpler CRISPR/Cas9 system has been so widely and rapidly adopted. Debates continue on the relative specificity and efficacy of CRISPR/Cas9 versus ZFN or TALEN technologies [<xref ref-type="bibr" rid="R25">25</xref>-<xref ref-type="bibr" rid="R29">29</xref>]; nevertheless, publication of CRISPR/Cas9 papers has soared in the past three years with no sign of slowing down (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<p><italic>What makes the CRISPR/Cas9 system more adoptable and adaptable compared with ZFN and TALEN technologies?</italic> Instead of a protein with intrinsic sequence-specific DNA binding activity, CRISPR/Cas9 uses an RNA-guided mechanism to recruit the Cas9 effector onto the genome. CRISPR/Cas is a naturally occurring nuclease system from bacteria that recognizes RNA-DNA hybrids, used as an innate form of defense against foreign DNA [<xref ref-type="bibr" rid="R30">30</xref>]. The Cas9 nuclease, the core module of the technology, is recruited to DNA upon expression of an RNA (guide RNA or gRNA) that includes a protospacer adjacent motif (PAM) to bind Cas9 [<xref ref-type="bibr" rid="R31">31</xref>-<xref ref-type="bibr" rid="R34">34</xref>]. Researchers have exploited the fact that different bacterial strains employ unique PAMs to multiplex with different Cas9 molecules and target different effectors to discrete genomic loci [<xref ref-type="bibr" rid="R35">35</xref>]. At less than $10 USD to synthesize a new gRNA, CRISPR/Cas9 is the only one of the three genome-editing tools useful for genome-scale screening [<xref ref-type="bibr" rid="R36">36</xref>].</p>
<p><italic>What modifications can be elicited by the recruitment of ZFNs, TALENs, or Cas9?</italic> ZFN, TALEN, and CRISPR/Cas9 nucleases all elicit double-stranded breaks (DSBs) that result in mutation of the underlying sequence via activation of endogenous DNA repair pathways: non-homologous end joining (NHEJ) and homology-directed repair (HDR) [<xref ref-type="bibr" rid="R37">37</xref>]. NHEJ simply ligates the broken ends, often generating insertions or deletions. HDR uses the sequence at the DSB as a template for repair for higher fidelity. When directed at gene regulatory elements, Cas9-induced mutations can reveal the requirement for transcription factor binding sites or other specific regions to activate a target gene.</p>
<p>To use the Cas9 protein as a platform for recruiting transcriptional effectors, the nuclease activity of Cas9 must be inactivated by mutation of specific amino acid residues on Cas9 in the RuvC and HNH domains [<xref ref-type="bibr" rid="R38">38</xref>]. The nuclease-dead Cas9 (known as dCas9) [<xref ref-type="bibr" rid="R39">39</xref>] serves as a powerful scaffold to target any effector to the genome by leveraging Cas9’s ability to bind to gRNAs that sit down at specific sites of interest.</p>
<p>To turn gene expression on or off, engineers have fused transcriptional activator or repression domains to ZFNs [<xref ref-type="bibr" rid="R40">40</xref>], TALENs, and most recently, dCas9 [<xref ref-type="bibr" rid="R41">41</xref>], and recruited them to non-coding regions. Recent development of more potent activators, such as dCas9-VPR that combines the VP64, p65, and Rta activators [<xref ref-type="bibr" rid="R42">42</xref>], may enable more robust targeting of distal regulatory elements situated up to megabases away from promoters they activate. CRISPR-based activation (CRISPRa) is predominantly used to demonstrate sufficiency of a regulatory element for gene transcription; conversely, CRISPR-mediated repression (CRISPRi) is an alternative for RNA interference, used to demonstrate that an element is necessary for efficient gene expression (<xref ref-type="fig" rid="F3">Figure 3</xref>). Furthermore, to study the function of site-specific modifications to the epigenome, researchers have fused synthetic DNA binding proteins to enzymes that alter the epigenetic landscape by inducing histone [<xref ref-type="bibr" rid="R43">43</xref>], DNA, and chromatin modifications. This form of manipulation is most practical for disambiguating whether sequence changes at the DNA level or chromatin state of regulatory elements is the dominant contributor to alterations in gene transcription. Various iterations of chemical- or light-inducible Cas9 are being developed to improve spatiotemporal resolution for activation of Cas9 or dCas9-based effectors [<xref ref-type="bibr" rid="R44">44</xref>-<xref ref-type="bibr" rid="R46">46</xref>].</p>
<p><italic>What are the continued technical challenges for CRISPR/Cas9 in neurons?</italic> One of the great challenges for any molecular genetic study is disambiguating the cause of phenotypic effects. Cellular phenotypes emerging from globally disrupting gene expression could be a direct effect of a specific gene in a given cell type; alternatively, they are indirect consequences of a disrupted cellular environment or altered development. To address this concern for <italic>in vivo</italic> studies of the brain, in utero electroporation (IUEs) or viral-based methods are widely used for pre- and post-natal gene manipulations in neurons respectively. In particular, adeno-associated viruses (AAVs) are frequently used for neuronal transgene expression because they exhibit low levels of toxicity and high levels of <italic>in vivo</italic> neuronal infection. However, AAVs are limited in the size of DNA they can carry and the size of Cas9 from <italic>Streptococcus pyogenes</italic> (4.2 kb) makes it impossible to package into a single AAV with the gRNA and associated scaffold. By contrast, <italic>Staphylococcus aureus</italic> Cas9 (saCas9) is only 3.3 kb [<xref ref-type="bibr" rid="R35">35</xref>]. This system is compatible with incorporating saCas9, gRNAs, and GFP into a single AAV vector for Cas9-dependent manipulation of the genome in post-mitotic neurons. saCas9 and spCas9 are recruited by different PAM sequences; thus, distinct gRNAs must be engineered for use in the two systems.</p>
<p>The ability to make precise mutations in the neuronal genome with Cas9 is critical to study the effect of discrete changes to gene regulatory elements. Cas9 is a highly active nuclease and it can routinely elicit multiple DSBs at targeted loci, leading to unwanted additional mutations. A recent method called CORRECT aims to overcome this challenge by simultaneously mutating the target sequence and the adjacent PAM to prevent re-targeting by Cas9 [<xref ref-type="bibr" rid="R47">47</xref>]. Moreover, the modeling of monogenic disorders caused by heterozygous mutations requires mutational knock-ins at single alleles. It turns out the rate of mutation incorporation is inversely related to the distance between the Cas9 cut site and the desired mutation; this fact is now exploited to elicit heterozygous mutations at a higher frequency by selecting PAM sites at specific distances from the variant to be introduced [<xref ref-type="bibr" rid="R47">47</xref>].</p>
<p>Potential off-target effects of CRISPR/Cas9 compound the issues discussed above; in other words, single gRNAs can inadvertently target Cas9 to more than one genomic location. Several experimental strategies are used to validate the specificity of CRISPR/Cas9 action directly with respect to gene regulation. dCas9 ChIP-seq can validate the protein is binding to a single genomic location [<xref ref-type="bibr" rid="R48">48</xref>,<xref ref-type="bibr" rid="R49">49</xref>]. An RNA-seq comparison between the introduction of Cas9 with and without a gRNA targeting gene regulatory elements ensures that expression of a single gene is altered by the manipulation [<xref ref-type="bibr" rid="R50">50</xref>]. Computational tools exist to evaluate efficiencies of genome editing events [<xref ref-type="bibr" rid="R51">51</xref>] and criteria for gRNA length and target selection to minimize off-target effects have been examined [<xref ref-type="bibr" rid="R52">52</xref>]. Improving the specificity of the CRISPR/Cas9 system is an extensive field of study and it has been reviewed in detail [<xref ref-type="bibr" rid="R53">53</xref>,<xref ref-type="bibr" rid="R54">54</xref>].</p>
</sec>
<sec id="s4" sec-type="discussion">
<title>CRISPR Applications in Neurobiology</title>
<sec id="s4a">
<title>Using CRISPR/Cas9 to Mutate Coding and Non-coding Elements</title>
<p>One of the principal applications for CRISPR/Cas9-based genome editing is knockout of specific genes of interest for functional studies. In this regard, CRISPR/Cas9 represents a more rapid way to make germline null alleles compared with homologous recombination [<xref ref-type="bibr" rid="R55">55</xref>,<xref ref-type="bibr" rid="R56">56</xref>]. Variations of the CRISPR/Cas9 method can also be used to make germline knock-in mutations and Cre-dependent expression of Cas9 permits conditional genome editing, though the efficiency of the CRISPR/Cas9 method compared with traditional genetic techniques for the generation of these more complex alleles remains to be fully established. What is most important for neurons, is that CRISPR/Cas9 genome editing represents a new way to achieve gene knockout in post-mitotic neurons [<xref ref-type="bibr" rid="R57">57</xref>-<xref ref-type="bibr" rid="R59">59</xref>]. By Cre-dependent Cas9 expression paired with transfection or infection of gRNAs, the CRISPR/Cas9 system has the temporal and cell-type specificity of RNA interference with the added benefit of potentially yielding complete knockout, rather than knockdown of gene expression in single cells [<xref ref-type="bibr" rid="R57">57</xref>].</p>
<p>However, beyond just knocking out genes by introducing indels into coding sequences, CRISPR/Cas9 genome editing can also be used to introduce function-disrupting mutations into non-coding gene regulatory elements. Because the non-coding genome is far more expansive than the coding genome, functional annotation of noncoding elements is substantially benefitted by the higher throughput nature of CRISPR/Cas9 compared with conventional homologous recombination. This method is particularly useful for interrogating the genomic control of brain development, as manipulating enhancer activity <italic>in situ</italic> can give insight into the finer mechanisms of genome regulation that give rise to neuronal diversity.</p>
<p>The murine retina is a model system of CNS neuronal diversification that is readily amenable to gene regulation studies. Differentiation is driven by a well-defined complement of transcription factors that regulate binary cell fate decisions [<xref ref-type="bibr" rid="R60">60</xref>,<xref ref-type="bibr" rid="R61">61</xref>], leading a highly stereotyped structure that facilitates discrimination of cellular phenotypes [<xref ref-type="bibr" rid="R62">62</xref>]. One such cell fate decision occurs in retinal progenitor cells that terminally divide to produce two cell types with distinct structures and functions: rod photoreceptors that capture light and bipolar cells that function as interneurons [<xref ref-type="bibr" rid="R63">63</xref>]. Blimp1, a transcription factor encoded by the <italic>Prdm1</italic> gene, is required for this differentiation; conditional knockout of <italic>Prdm1</italic> leads to excess bipolar cells, suggesting that Blimp1 drives photoreceptor fate. Wang et al. [<xref ref-type="bibr" rid="R64">64</xref>] identified a putative <italic>Prdm1</italic> enhancer that correlates with the developmental time course of Blimp1 protein expression. Fate mapping revealed that the putative enhancer was most active in the progenitors that would ultimately become rods, not in those that differentiated into bipolar cells. The authors used CRISPR/Cas9 to delete the putative <italic>Prdm1</italic> enhancer in the mouse retina at P0 to demonstrate its requirement for proper <italic>Prdm1</italic> expression and rod photoreceptor fate. Loss of the enhancer resulted in an excess of bipolar cells phenocopying the <italic>Prdm1</italic> conditional knockout, suggesting that this distal <italic>cis</italic>-regulatory element is essential for <italic>Prdm1</italic> expression in the retina during early postnatal development. Enhancer deletions have long been accomplished using HR in ES cells [<xref ref-type="bibr" rid="R65">65</xref>], though the CRISPR/Cas9 method has potential advantages. It is faster to generate deletions, potentially allowing for screening of multiple putative enhancers in parallel. Furthermore, enhancer mutations can be introduced into a subset of cells at a specific developmental timepoint. For genes that have pleotropic functions during development, the precision of these enhancer mutations can improve temporal resolution on our understanding of gene regulation in development.</p>
<p>Enhancers are robust substrates for evolutionary change that manifests in tissue-specific gene expression changes [<xref ref-type="bibr" rid="R66">66</xref>,<xref ref-type="bibr" rid="R67">67</xref>]. At the same time, sequence variation at enhancers can also result in CNS cellular dysfunction and disease [<xref ref-type="bibr" rid="R68">68</xref>-<xref ref-type="bibr" rid="R70">70</xref>] in a cell type-specific manner [<xref ref-type="bibr" rid="R71">71</xref>]. It remains a considerable hurdle to gain mechanistic insight into how single nucleotide variants (SNVs) and other genetic variants identified in genome-wide association studies cause disease in the CNS [<xref ref-type="bibr" rid="R72">72</xref>]. It is suggested that many of disease-associated SNVs alter local chromatin and histone state, falling within genomic regions that occlude endogenous transcriptional regulators [<xref ref-type="bibr" rid="R73">73</xref>,<xref ref-type="bibr" rid="R74">74</xref>]. Soldner et al. [<xref ref-type="bibr" rid="R75">75</xref>] have used CRISPR/Cas9 to address Parkinson’s disease cases without clear Mendelian inheritance patterns, which accounts for up to 90 percent of patients. Since enhancers are thought to modulate gene expression, they sought genomic regions with active epigenetic signatures in the substantia nigra of post-mortem Parkinson’s patients. They found putative enhancers in an intronic region of SNCA and in the 3’ UTR that are proposed to regulate α-synuclein expression. Soldner et al. [<xref ref-type="bibr" rid="R75">75</xref>] recapitulated the disease genotype by deleting the putative enhancer elements by CRISPR/Cas9-mediated genome editing in human ES cells and restoring the regions with known variants from Parkinson’s patients (<xref ref-type="fig" rid="F3">Figure 3</xref>A) before differentiating cells into neural precursors. The resultant neuronal cultures were useful because they enabled the study of allele-specific differences in epigenetic marks indicative of enhancer activity, as well as the disruption of binding of key transcription factors in human cortical function (EMX2, NKX6-1) by enhancer sequence variation observed in Parkinson’s patients. With improved AAVs for introducing CRISPR/Cas9 to the CNS [<xref ref-type="bibr" rid="R76">76</xref>,<xref ref-type="bibr" rid="R77">77</xref>], there is a promising platform to correct such variants in brain-specific enhancer regions.</p>
<p>Looking ahead, simultaneous targeting of multiple enhancers will be a useful tool to test the combinatorial nature of enhancer-promoter activation [<xref ref-type="bibr" rid="R78">78</xref>]. Moreover, high-throughout CRISPR/Cas9-based enhancer screens [<xref ref-type="bibr" rid="R79">79</xref>-<xref ref-type="bibr" rid="R81">81</xref>] are emerging to tile tens of kilobases of genomic search space in an unbiased manner for <italic>cis</italic>-regulatory activity, or for understanding the hierarchy of transcription factor binding sites within these enhancers. The studies highlighted in this section are some of the first to utilize CRISPR/Cas9 technology to dissect both the <italic>cis</italic>- and <italic>trans</italic>-regulators of gene expression in neurons and can be paired with improved cell type-specific sorting methods [<xref ref-type="bibr" rid="R82">82</xref>,<xref ref-type="bibr" rid="R83">83</xref>] in future to learn about the functional diversity of transcriptional regulation across neuronal and glial subtypes of mammalian brain.</p>
</sec>
<sec id="s4b">
<title>Using CRISPR/Cas9 to Watch Gene Expression in Living Cells</title>
<p>The classic model for enhancer activation of gene expression includes the interaction between enhancer and promoter to recruit transcriptional co-activators nearby transcription start sites to initiate gene expression (<xref ref-type="fig" rid="F1">Figure 1</xref>). At the moment, there are limited strategies to monitor these biophysical interactions that result in the formation of so-called chromatin loops. These include chromatin capture to provide an aggregate measure of chromatin interactions across all cells in a population [<xref ref-type="bibr" rid="R84">84</xref>], though this often lacks the resolution required to study neuronal subtype-specific enhancers. Alternatively, two-color DNA fluorescence <italic>in situ</italic> hybridization (FISH) [<xref ref-type="bibr" rid="R85">85</xref>] is an approach that enables cell type-specific resolution (co-localization of two fluorophore labeled probes is indicative of a chromosomal interaction between the putative enhancer and promoter being targeted), but for only one set of loci at a time and in fixed cells. Since there is some evidence to suggest that these chromatin loops are transient interactions between enhancer and promoter [<xref ref-type="bibr" rid="R86">86</xref>], it would be particularly useful to visualize these interactions in real-time in living cells. To that end, some labs have developed new techniques to recruit dCas9 fused to a variety of fluorophores that are targeted to distinct loci in the genome as an alternative to DNA FISH that is more efficient for multiplexing purposes [<xref ref-type="bibr" rid="R87">87</xref>,<xref ref-type="bibr" rid="R88">88</xref>].</p>
<p>For cellular localization of RNAs, RNA FISH is a robust method whereby DNA probes fused to fluorophores are allowed to hybridize to complementary RNA sequences of interest for their visualization [<xref ref-type="bibr" rid="R89">89</xref>], a technique that has been used for neurons <italic>in vitro</italic> and <italic>in vivo</italic>. Yet again, although this technology is sufficient to detect and quantify individual single RNA molecules at cellular resolution [<xref ref-type="bibr" rid="R90">90</xref>], they require that neurons be fixed at a given time point, which severely limits temporal resolution on transcriptional analysis. To address this gap, researchers have developed live imaging systems that rely on the complementarity of gRNAs to target RNAs to recruit dCas9 fused with fluorescent proteins [<xref ref-type="bibr" rid="R91">91</xref>]. This approach could be highly useful for studying dynamic gene expression programs in the brain, such as neuronal activity-dependent transcription. This process includes a wave of delayed primary response genes that could be interesting to track with CRISPR/dCas9, because they are often cell type-specific and enriched for diverse synaptic functions [<xref ref-type="bibr" rid="R92">92</xref>]. Moreover, given the observation that RNA-binding proteins (RBPs) enable the trafficking of specific RNAs to specialized neuronal compartments (e.g. dendrites vs. axons) for local translation [<xref ref-type="bibr" rid="R93">93</xref>], CRISPR/dCas9-mediated RNA live imaging could be an important tool for determining the components present in individual RNA granules as they are translocated by RBPs [<xref ref-type="bibr" rid="R94">94</xref>].</p>
<p>Lastly, localization of newly synthesized proteins from dynamic neuronal processes in the mammalian brain, such as neuronal activity- or neurotrophin-induced transcription, is relevant because they represent the functional output of gene regulation. Several groups have employed CRISPR/Cas9 gene editing to knock in small epitope tags following the open reading frame for a protein of interest in the nervous system, specifically in the context of the Drosophila olfactory system [<xref ref-type="bibr" rid="R95">95</xref>,<xref ref-type="bibr" rid="R96">96</xref>]. Within the mammalian brain, generating conditional knock-in mice to tag a protein with a small epitope is a common approach to study cell type-specific functions of proteins. Leveraging the potential of mitotic neural progenitors in mice for HDR, Mikuni et al. [<xref ref-type="bibr" rid="R97">97</xref>] recently published a technique known as single-cell labeling of endogenous proteins by CRISPR/Cas9-mediated homology-directed repair (SLENDR). SLENDR permits the knock-in of small epitopes adjacent to neuronal genes of interest in single progenitors by IUE of CRISPR/Cas9 machinery into the embryonic mouse brain (<xref ref-type="fig" rid="F3">Figure 3</xref>B). As proof of principle, Mikuni et al. [<xref ref-type="bibr" rid="R97">97</xref>] knocked in an HA tag adjacent to the CaMKIIβ locus to achieve nanometer-scale resolution of CaMKIIβ localization by electron microscopy. SLENDR was also used to localize cytoskeletal proteins (β-actin) within the context of a sparse knockout by CRISPR/Cas9 (of methyl-CpG-binding protein 2 or MeCP2), which allows the study of cell-autonomous protein function of normal and knockout cells in the same tissue.</p>
<p>Overall, these CRISPR/Cas9-based approaches are powerful because they enable both temporal and spatial specificity to the imaging of a protein that is transcribed and translated within cells from its native genomic locus, which could shed light on the function of the protein in its endogenous gene regulatory context. To this end, as described below, several groups have developed CRISPR/Cas9 approaches to localize transcriptional regulators to specific genomic loci, an elegant approach to probe the function of a given <italic>cis</italic>-regulatory element to gene transcription and downstream functional consequences to neurons.</p>
</sec>
<sec id="s4c">
<title>Activation and Repression of <italic>cis</italic>-regulatory Elements in their Endogenous Context</title>
<p>The ability of synthetic DNA binding proteins to recognize coordinates in the genome with high specificity can be expanded beyond the editing of DNA sequences. As we describe above, in all three of the genome editing methods, researchers have also co-opted the specificity of protein-DNA or RNA-DNA binding to recruit transcriptional co-activators and co-repressors to specific loci of interest, with the goal of interrogating the function of these regulatory elements in their endogenous chromatin context. This expands the traditional toolbox for neurobiologists to study <italic>cis</italic>-regulatory elements beyond plasmid-based reporter assays that often fail to faithfully recapitulate an enhancer’s level of activity in its endogenous locus of the neuronal genome.</p>
<p>Recruitment of nuclease-dead dCas9 alone to promoter or enhancer elements by gRNAs has been shown to occlude endogenous transcriptional activators from accessing chromatin, likely by blocking relevant transcription factor binding sites, to reduce the activity of these <italic>cis</italic>-regulatory elements [<xref ref-type="bibr" rid="R98">98</xref>,<xref ref-type="bibr" rid="R99">99</xref>]. However, a more powerful strategy to functionally annotate genome regulatory elements is to fuse the synthetic DNA binding protein with a transcriptional regulatory domain. Examples include dCas9 fusion proteins that incorporate activators, such as VP64 [<xref ref-type="bibr" rid="R100">100</xref>,<xref ref-type="bibr" rid="R101">101</xref>] and p65 [<xref ref-type="bibr" rid="R102">102</xref>], which serve to recruit RNA pol II and associated general transcriptional machinery to DNA loci of interest. Studies targeting dCas9-VP64 to promoters [<xref ref-type="bibr" rid="R50">50</xref>,<xref ref-type="bibr" rid="R103">103</xref>] and even enhancers located distally to target genes [<xref ref-type="bibr" rid="R16">16</xref>,<xref ref-type="bibr" rid="R104">104</xref>] have been shown to be sufficient to activate expression of relevant target genes outside the context of the nervous system [<xref ref-type="bibr" rid="R105">105</xref>]. Importantly, VP64 recruitment is thought to function by the addition of relevant epigenetic signatures associated with active regulatory regions [<xref ref-type="bibr" rid="R106">106</xref>]. These specifically mediate increased chromatin accessibility as quantified by DNase-seq or ATAC-seq, as well as increased acetylation of lysine 27 of histone H3 (H3K27ac) and increased methylation of lysine 4 of histone H3 (H3K4me1 and H3K4me3) as determined by ChIP-seq, all indicators of active DNA regulatory elements.</p>
<p>Recent studies have demonstrated the efficacy of this approach by exogenously activating enhancers in specific neuronal populations. Frank et al. [<xref ref-type="bibr" rid="R16">16</xref>] characterized genome-wide chromatin accessibility changes and epigenetic marks (DNase-seq and H3K27ac ChIP-seq respectively) to identify thousands of putative regulatory elements that are dynamically turned on and off at discrete stages of neuronal differentiation in the cerebellum. The authors selected specific enhancers to target by dCas9-VP64 based on epigenomic features and transcription factor occupancy. Localizing dCas9-VP64 to two putative enhancers in a gene-dense region demonstrated the selective activation of a single gene (<italic>Grin2c</italic>) among many situated within this genomic locus. This study is important because it validated the function and gene targets of putative neuronal enhancers in their endogenous chromatin and cellular context. Moreover, it enabled the robust empirical identification of a specific target gene associated with each enhancer, which is otherwise limited to bioinformatics methods [<xref ref-type="bibr" rid="R107">107</xref>].</p>
<p>Similarly, a series of dCas9-based transcriptional repressors have been optimized as a complement to the dCas9-VP64 co-activator. This set of reagents is especially useful in the context of studying enhancers because repression of potentially active <italic>cis</italic>-regulatory elements enables neurobiologists to quantitatively determine the requirement for any given enhancer to a gene’s proper expression level in neurons. In particular, dCas9 has been fused with the Krupel-associated box (KRAB) domain found in zinc-finger transcription factors [<xref ref-type="bibr" rid="R108">108</xref>]. KRAB is thought to mediate repression by binding to DNA and recruiting heterochromatin-forming protein complexes [<xref ref-type="bibr" rid="R109">109</xref>] to remodel the local epigenetic state, inducing the methylation of lysine 9 of histone H3 (H3K9me) [<xref ref-type="bibr" rid="R110">110</xref>], an epigenetic mark indicative of constitutive heterochromatin. dCas9-KRAB recruitment to gene regulatory regions has been shown to require only a single gRNA for efficient targeting and repression and it has been applied to study both proximal and distal regulatory elements [<xref ref-type="bibr" rid="R111">111</xref>].</p>
<p>Recently, Joo et al. [<xref ref-type="bibr" rid="R112">112</xref>] employed dCas9-KRAB to interrogate the function of distal enhancers in the activation of <italic>Fos</italic>, a well-characterized transcription factor [<xref ref-type="bibr" rid="R113">113</xref>] that is known to be induced by a variety of extracellular stimuli. Prior studies of <italic>Fos</italic> in the context of neuronal activity have described a set of five putative activity-regulated enhancers that regulate <italic>Fos</italic> [<xref ref-type="bibr" rid="R3">3</xref>], each of which show induction of the H3K27ac epigenetic mark associated with active regulatory elements upon neuronal stimulation [<xref ref-type="bibr" rid="R4">4</xref>]. Joo et al. describe in their study that while the <italic>Fos</italic> gene is activated in neurons by diverse stimuli, including neuronal activity and neurotrophin signaling, individual <italic>Fos</italic> enhancers are differentially responsive to each of these activating signals. In particular, they demonstrate by dCas9-KRAB recruitment to each of the five enhancers that they are able to reduce enhancer RNA levels, an epigenetic readout of enhancer activity [<xref ref-type="bibr" rid="R114">114</xref>], and <italic>Fos</italic> transcripts at the mRNA level in a stimulus-specific manner. This method is an illustration of how CRISPR interference (CRISPRi, <xref ref-type="fig" rid="F3">Figure 3</xref>C) is able to dissect the functional contribution of each non-coding <italic>cis</italic>-regulatory element to the neuron’s ability to initiate transcription of a single gene, which will lend insight into how more complex gene expression programs are regulated by the non-coding genome and its epigenomic state.</p>
</sec>
<sec id="s4d">
<title>CRISPR/dCas9-based Epigenome Editing</title>
<p>In recent years, seminal work in the field of neuroepigenetics has revealed the importance of stimulus-dependent changes in the epigenome, which includes a complex array of DNA modifications and post-translational modifications to histone proteins, for the regulation of neuronal gene expression. Within all cells, there exists an interplay between two broad families of proteins: epigenetic enzymes or effectors, which catalyze reactions that result in biochemical changes, and epigenetic readers, which interpret these biochemical changes and facilitate the active recruitment of transcriptional co-factors to modulate gene expression. The interesting part in neurons is that the expression and function of many of these chromatin regulatory factors is subject to neuronal activity-dependent regulation, leading to correlations in epigenome changes with functionally relevant properties of neurons, such as synaptic plasticity. This biochemical plasticity of chromatin adds an additional layer of complexity to gene regulation beyond <italic>cis</italic>-regulatory element sequences, a realization that has prompted some seminal work to uncover the epigenomic code of the neuron [<xref ref-type="bibr" rid="R115">115</xref>,<xref ref-type="bibr" rid="R116">116</xref>] and how these epigenetic changes might alter behavioral output in mouse models [<xref ref-type="bibr" rid="R117">117</xref>,<xref ref-type="bibr" rid="R118">118</xref>].</p>
<p>Among the biochemical modifications of histone proteins used to identify specific classes of gene regulatory elements, one of the best known is the acetylation of lysine 27 at histone H3 (H3K27ac), shown to be highly correlated with active regulatory elements that are both proximally and distally situated relative to the TSS [<xref ref-type="bibr" rid="R119">119</xref>,<xref ref-type="bibr" rid="R120">120</xref>]. The histone acetyltransferase p300 has been shown to deposit this specific post-translational modification [<xref ref-type="bibr" rid="R121">121</xref>] and is bound widely to active neuronal enhancers [<xref ref-type="bibr" rid="R3">3</xref>]. Due to the association of acetylation of particular histone residues at <italic>cis</italic>-regulatory elements with activation of gene transcription, it is possible that epigenomic editing of the histone acetylation state could be co-opted as a powerful resource for activating genes. Hilton et al. [<xref ref-type="bibr" rid="R122">122</xref>] have optimized a dCas9-p300 fusion protein (<xref ref-type="fig" rid="F3">Figure 3</xref>D), which has been targeted to both promoters and distal enhancers to robustly activate genes, often to a greater degree than dCas9-VP64 recruitment. Although other chromatin modifying enzymes have not yet been fused to dCas9, Konermann et al. [<xref ref-type="bibr" rid="R123">123</xref>] have introduced a TALE fusion protein linked to SIN3 transcriptional regulator family member A (SIN3A) to neurons, which removes a histone acetylation mark (H3K9ac) that is functionally similar to H3K27ac. When recruited to the <italic>Grm2</italic> promoter, TALE-Sin3a significantly reduced H3K9ac and concurrently diminished <italic>Grm2</italic> expression in Neuro-2a cells. These histone-specific epigenetic editors provide neurobiologists with a molecular handle to activate and repress genes in neurons, as well as to investigate the epigenomic code and its role neuronal gene regulation.</p>
<p>The most common epigenetic mark associated with DNA is the methylation of cytosines at the C5 position (5mC), which has historically been studied in the context of CpG (CG) dinucleotides and is associated with repression of gene expression. The importance of DNA methylation in the mammalian brain was brought home by the discovery that mutations in the methyl-DNA binding protein <italic>MECP2</italic> cause Rett syndrome, an X-linked neurological disorder [<xref ref-type="bibr" rid="R124">124</xref>,<xref ref-type="bibr" rid="R125">125</xref>]. The major enzymes responsible for depositing methyl groups on cytosine are the <italic>de novo</italic> methyltransferases 3A (Dnmt3a) and 3B (Dnmt3b) [<xref ref-type="bibr" rid="R126">126</xref>]. The level of Dnmt3a expression peaks in the mammalian brain relatively early in postnatal development [<xref ref-type="bibr" rid="R127">127</xref>], a period that is critical for proper neuronal circuit formation and refinement. Mouse models with <italic>Mecp2</italic> mutations [<xref ref-type="bibr" rid="R128">128</xref>,<xref ref-type="bibr" rid="R129">129</xref>], as well as conditional <italic>Dnmt3a</italic> knockouts [<xref ref-type="bibr" rid="R130">130</xref>], both display a vast array of neurobiological deficits, underscoring the importance of this epigenetic modification for normal brain development and function. Interestingly, recent studies also show that non-CG methylation is highly enriched in the mammalian brain, is deposited by Dnmt3a [<xref ref-type="bibr" rid="R131">131</xref>], and is bound by MeCP2 [<xref ref-type="bibr" rid="R132">132</xref>]. Finally, 5-methylcytosine (5mC) can be converted to 5-hydroxymethylcytosine (5hmC) by a series of dioxygenases termed the ten-eleven translocation (TET) family [<xref ref-type="bibr" rid="R133">133</xref>]. Studies have shown that 5hmC is an epigenetic mark present in the mammalian brain [<xref ref-type="bibr" rid="R134">134</xref>], that 5hmC is dynamically regulated in development [<xref ref-type="bibr" rid="R135">135</xref>], and that cell type-specific patterns of 5hmC in the genome are present in active genes [<xref ref-type="bibr" rid="R136">136</xref>].</p>
<p>To develop new tools for DNA methylation analysis, Swiech et al. [<xref ref-type="bibr" rid="R59">59</xref>] generated adeno-associated viruses for Cas9, as well as for gRNAs targeting <italic>Dnmt3a</italic>, <italic>Dnmt3b</italic>, and <italic>Dnmt1</italic>, the methyltransferase responsible for maintaining DNA methylation patterns over cell division. <italic>Dnmt3a</italic> has been fused with TALENs [<xref ref-type="bibr" rid="R137">137</xref>,<xref ref-type="bibr" rid="R138">138</xref>] and Cas9 [<xref ref-type="bibr" rid="R139">139</xref>,<xref ref-type="bibr" rid="R140">140</xref>] and shown to mediate site-specific regulation of DNA methylation. Finally, there is TALEN technology incorporating the Tet1 catalytic domain [<xref ref-type="bibr" rid="R141">141</xref>] and some work has been done to generate a mouse ES cell line deficient in all three TET family members with CRISPR/Cas9 technology [<xref ref-type="bibr" rid="R142">142</xref>]. This is an example of where the modular nature of CRISPR/Cas9 could promote rapid development of new tools to probe the function and mechanism of the epigenome in the nervous system (<xref ref-type="table" rid="T1">Table 1</xref>). In fact, groups have very recently developed and applied new dCas9-Tet1 and dCas9-Dnmt3a fusion proteins to increase our epigenome editing capacity in neurons [<xref ref-type="bibr" rid="R143">143</xref>].</p>
</sec>
</sec>
<sec id="s5" sec-type="conclusions">
<title>Conclusions and Outlook</title>
<p>Neurobiologists have just begun to explore the cellular and molecular mechanisms that enable the epigenomic landscape of <italic>cis</italic>-regulatory elements to deploy transcriptional programs over brain development and in response to neuronal activity. The innovation of CRISPR/Cas9-based epigenetic effectors will accelerate this process of discovery, as the ability to target multiple regulatory elements with high specificity and efficiency will fuel the functional annotation of the genome. The genome and epigenome editing toolbox made possible by the simple and modular design of the CRISPR/Cas9 system can easily be paired with cutting-edge genetic and microscopy techniques to improve resolution on specific epigenomic features of different neuronal cell types. One of the key frontiers for the future will be using CRISPR/Cas9 methods to push the boundaries of understanding transcriptional regulation at the single-cell level. This experimental capacity is especially important in the brain, where the precise interconnection of multiple cell types is key for the function of neural circuits and where information is stored in distributed networks [<xref ref-type="bibr" rid="R144">144</xref>]. In 2015, single-cell methods emerged for quantifying RNA transcripts [<xref ref-type="bibr" rid="R145">145</xref>,<xref ref-type="bibr" rid="R146">146</xref>], histone epigenetic modifications [<xref ref-type="bibr" rid="R147">147</xref>], and chromatin accessibility [<xref ref-type="bibr" rid="R148">148</xref>]. An advantage that single-cell technologies provide over previous cell type purification-based methods is the ability to quantify CRISPR/Cas9 effects in a largely unbiased manner. In other words, we now have the ability to profile the transcriptional state before and after CRISPR/Cas9 manipulations of all neurons in a population and we may even discover novel gene regulatory patterns in neurons not defined by a single cell type marker. As we look towards the future of neuroepigenomics, CRISPR/Cas9 developments will continue to expand the possibilities for neurobiologists to understand normal brain development and function, as well as how the chromatin landscape is perturbed in neurologicaldisorders [<xref ref-type="bibr" rid="R149">149</xref>].</p>
</sec>
</body>
<back>
<ack>
<p>We thank Emmy Li for assistance with figures.</p>
</ack>
<notes>
<title>Author Contributions</title>
<p>Marty Yang and Anne West both conceived of the idea, wrote the paper, edited the paper, and designed the figures. This work was supported by NIH grant DA041878 to A.E.W.</p>
</notes>
<glossary>
<def-list>
<def-item>
<term>CRISPR</term>
<def>
<p>clustered regularly interspaced short palindromic repeats</p>
</def>
</def-item>
<def-item>
<term>DBD</term>
<def>
<p>DNA binding domain</p>
</def>
</def-item>
<def-item>
<term>TAD</term>
<def>
<p>transcriptional activation domain</p>
</def>
</def-item>
<def-item>
<term>ZFN</term>
<def>
<p>zinc finger nuclease</p>
</def>
</def-item>
<def-item>
<term>TALEN</term>
<def>
<p>transcription activator-like effector nucleases</p>
</def>
</def-item>
<def-item>
<term>PAM</term>
<def>
<p>protospacer adjacent motif</p>
</def>
</def-item>
<def-item>
<term>gRNA</term>
<def>
<p>guide RNA</p>
</def>
</def-item>
<def-item>
<term>HDR</term>
<def>
<p>homology directed repair</p>
</def>
</def-item>
<def-item>
<term>NEHJ</term>
<def>
<p>non-homologous end-joining</p>
</def>
</def-item>
<def-item>
<term>dCas9</term>
<def>
<p>nuclease-dead Cas9</p>
</def>
</def-item>
<def-item>
<term>SNP</term>
<def>
<p>single nucleotide polymorphism</p>
</def>
</def-item>
<def-item>
<term>FISH</term>
<def>
<p>fluorescence in situ hybridization</p>
</def>
</def-item>
<def-item>
<term>RBP</term>
<def>
<p>RNA binding protein</p>
</def>
</def-item>
<def-item>
<term>SLENDR</term>
<def>
<p>single cell labeling of endogenous proteins by CRISPR-Cas9-mediated homology-directed repair</p>
</def>
</def-item>
</def-list>
</glossary>
<ref-list>
<ref id="R1">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Alarcón</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Malleret</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Touzani</surname>
<given-names>K</given-names>
</name>
<etal></etal>
<article-title>Chromatin Acetylation, Memory, and LTP Are Impaired in CBP+/− Mice.</article-title>
<source/>Neuron
          <year>2004</year>
<volume>42</volume>
<issue>6</issue>
<fpage>947</fpage>
<lpage>959</lpage>
<pub-id pub-id-type="pmid">15207239</pub-id>
</element-citation>
</ref>
<ref id="R2">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Korzus</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Mayford</surname>
<given-names>M</given-names>
</name>
<article-title>CBP Histone Acetyltransferase Activity Is a Critical Component of Memory Consolidation.</article-title>
<source/>Neuron
          <year>2004</year>
<volume>42</volume>
<issue>6</issue>
<fpage>961</fpage>
<lpage>972</lpage>
<pub-id pub-id-type="pmid">15207240</pub-id>
</element-citation>
</ref>
<ref id="R3">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Kim</surname>
<given-names>T-K</given-names>
</name>
<name>
<surname>Hemberg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>JM</given-names>
</name>
<etal></etal>
<article-title>Widespread transcription at neuronal activity-regulated enhancers.</article-title>
<source/>Nature
          <year>2010</year>
<volume>465</volume>
<issue>7295</issue>
<fpage>182</fpage>
<lpage>187</lpage>
<pub-id pub-id-type="pmid">20393465</pub-id>
</element-citation>
</ref>
<ref id="R4">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Malik</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Vierbuchen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hemberg</surname>
<given-names>M</given-names>
</name>
<etal></etal>
<article-title>Genome-wide identification and characterization of functional neuronal activity-dependent enhancers.</article-title>
<source/>Nat Neurosci
          <year>2014</year>
<volume>17</volume>
<issue>10</issue>
<fpage>1</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="pmid">24369367</pub-id>
</element-citation>
</ref>
<ref id="R5">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Pattabiraman</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Golonzhka</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Lindtner</surname>
<given-names>S</given-names>
</name>
<etal></etal>
<article-title>Transcriptional Regulation of Enhancers Active in Protodomains of the Developing Cerebral Cortex.</article-title>
<source/>Neuron
          <year>2014</year>
<volume>82</volume>
<issue>5</issue>
<fpage>989</fpage>
<lpage>1003</lpage>
<pub-id pub-id-type="pmid">24814534</pub-id>
</element-citation>
</ref>
<ref id="R6">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Song</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Grasfeder</surname>
<given-names>LL</given-names>
</name>
<etal></etal>
<article-title>Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity.</article-title>
<source/>Genome Res
          <year>2011</year>
<volume>21</volume>
<issue>10</issue>
<fpage>1757</fpage>
<lpage>1767</lpage>
<pub-id pub-id-type="pmid">21750106</pub-id>
</element-citation>
</ref>
<ref id="R7">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Heintzman</surname>
<given-names>ND</given-names>
</name>
<name>
<surname>Hon</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Hawkins</surname>
<given-names>RD</given-names>
</name>
<etal></etal>
<article-title>Histone modifications at human enhancers reflect global cell-type-specific gene expression.</article-title>
<source/>Nature
          <year>2009</year>
<volume>459</volume>
<issue>7243</issue>
<fpage>108</fpage>
<lpage>112</lpage>
<pub-id pub-id-type="pmid">19295514</pub-id>
</element-citation>
</ref>
<ref id="R8">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Koch</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Andrews</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Flicek</surname>
<given-names>P</given-names>
</name>
<etal></etal>
<article-title>The landscape of histone modifications across 1% of the human genome in five human cell lines.</article-title>
<source/>Genome Res
          <year>2007</year>
<volume>17</volume>
<issue>6</issue>
<fpage>691</fpage>
<lpage>707</lpage>
<pub-id pub-id-type="pmid">17567990</pub-id>
</element-citation>
</ref>
<ref id="R9">
<element-citation publication-format="print" publication-type="journal">
<collab>ENCODE Project Consortium</collab>
<article-title>The ENCODE (ENCyclopedia Of DNA Elements) Project.</article-title>
<source/>Science
          <year>2004</year>
<volume>306</volume>
<issue>5696</issue>
<fpage>636</fpage>
<lpage>640</lpage>
<pub-id pub-id-type="pmid">15499007</pub-id>
</element-citation>
</ref>
<ref id="R10">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Visel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Minovitsky</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dubchak</surname>
<given-names>I</given-names>
</name>
<etal></etal>
<article-title>VISTA Enhancer Browser--a database of tissue-specific human enhancers.</article-title>
<source/>Nucleic Acids Res
          <year>2007</year>
<volume>35</volume>
<issue>Database issue</issue>
<fpage>D88</fpage>
<lpage>D92</lpage>
<pub-id pub-id-type="pmid">17130149</pub-id>
</element-citation>
</ref>
<ref id="R11">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Gray</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>P</given-names>
</name>
<etal></etal>
<article-title>Mouse brain organization revealed through direct genome-scale TF expression analysis.</article-title>
<source/>Science
          <year>2004</year>
<volume>306</volume>
<issue>5705</issue>
<fpage>2255</fpage>
<lpage>2257</lpage>
<pub-id pub-id-type="pmid">15618518</pub-id>
</element-citation>
</ref>
<ref id="R12">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Lyons</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>West</surname>
<given-names>AE</given-names>
</name>
<article-title>Mechanisms of specificity in neuronal activity-regulated gene transcription.</article-title>
<source/>Progress in Neurobiology
          <year>2011</year>
<volume>94</volume>
<issue>3</issue>
<fpage>259</fpage>
<lpage>295</lpage>
<pub-id pub-id-type="pmid">21620929</pub-id>
</element-citation>
</ref>
<ref id="R13">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>West</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>ME</given-names>
</name>
<article-title>Neuronal activity-regulated gene transcription in synapse development and cognitive function.</article-title>
<source/>Cold Spring Harb Perspect Biol
          <year>2011</year>
<volume>3</volume>
<issue>6</issue>
<fpage>a005744</fpage>
<pub-id pub-id-type="pmid">21555405</pub-id>
</element-citation>
</ref>
<ref id="R14">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Gray</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>West</surname>
<given-names>AE</given-names>
</name>
<etal></etal>
<article-title>Genomic Views of Transcriptional Enhancers: Essential Determinants of Cellular Identity and Activity-Dependent Responses in the CNS.</article-title>
<source/>J Neurosci
          <year>2015</year>
<volume>35</volume>
<issue>41</issue>
<fpage>13819</fpage>
<lpage>13826</lpage>
<pub-id pub-id-type="pmid">26468181</pub-id>
</element-citation>
</ref>
<ref id="R15">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Levine</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cattoglio</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tjian</surname>
<given-names>R</given-names>
</name>
<article-title>Looping Back to Leap Forward: Transcription Enters a New Era.</article-title>
<source/>Cell
          <year>2014</year>
<volume>157</volume>
<issue>1</issue>
<fpage>13</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="pmid">24679523</pub-id>
</element-citation>
</ref>
<ref id="R16">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Frank</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Wijayatunge</surname>
<given-names>R</given-names>
</name>
<etal></etal>
<article-title>Regulation of chromatin accessibility and Zic binding at enhancers in the developing cerebellum.</article-title>
<source/>Nature
          <year>2015</year>
<volume>18</volume>
<issue>5</issue>
<fpage>1</fpage>
<lpage>13</lpage>
</element-citation>
</ref>
<ref id="R17">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Kim</surname>
<given-names>YG</given-names>
</name>
<name>
<surname>Cha</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chandrasegaran</surname>
<given-names>S</given-names>
</name>
<etal></etal>
<article-title>Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain.</article-title>
<source/>Proc Natl Acad Sci USA
          <year>1996</year>
<volume>93</volume>
<issue>3</issue>
<fpage>1156</fpage>
<lpage>1160</lpage>
<pub-id pub-id-type="pmid">8577732</pub-id>
</element-citation>
</ref>
<ref id="R18">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Knapska</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kaczmarek</surname>
<given-names>L</given-names>
</name>
<article-title>A gene for neuronal plasticity in the mammalian brain: Zif268/Egr-1/NGFI-A/Krox-24/TIS8/ZENK?</article-title>
<source/>Progress in Neurobiology
          <year>2004</year>
<volume>74</volume>
<issue>4</issue>
<fpage>183</fpage>
<lpage>211</lpage>
<pub-id pub-id-type="pmid">15556287</pub-id>
</element-citation>
</ref>
<ref id="R19">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Palm</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Belluardo</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Metsis</surname>
<given-names>M</given-names>
</name>
<etal></etal>
<article-title>Neuronal expression of zinc finger transcription factor REST/NRSF/XBR gene.</article-title>
<source/>J Neurosci
          <year>1998</year>
<volume>18</volume>
<issue>4</issue>
<fpage>1280</fpage>
<lpage>1296</lpage>
<pub-id pub-id-type="pmid">9454838</pub-id>
</element-citation>
</ref>
<ref id="R20">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Boxer</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Barajas</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>S</given-names>
</name>
<etal></etal>
<article-title>ZNF750 interacts with KLF4 and RCOR1, KDM1A, and CTBP1/2 chromatin regulators to repress epidermal progenitor genes and induce differentiation genes.</article-title>
<source/>Genes Dev
          <year>2014</year>
<volume>28</volume>
<issue>18</issue>
<fpage>2013</fpage>
<lpage>2026</lpage>
<pub-id pub-id-type="pmid">25228645</pub-id>
</element-citation>
</ref>
<ref id="R21">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Urnov</surname>
<given-names>FD</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y-L</given-names>
</name>
<etal></etal>
<article-title>Highly efficient endogenous human gene correction using designed zinc-finger nucleases.</article-title>
<source/>Nature
          <year>2005</year>
<volume>435</volume>
<issue>7042</issue>
<fpage>646</fpage>
<lpage>651</lpage>
<pub-id pub-id-type="pmid">15806097</pub-id>
</element-citation>
</ref>
<ref id="R22">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Boch</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Scholze</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Schornack</surname>
<given-names>S</given-names>
</name>
<etal></etal>
<article-title>Breaking the code of DNA binding specificity of TAL-type III effectors.</article-title>
<source/>Science
          <year>2009</year>
<volume>326</volume>
<issue>5959</issue>
<fpage>1509</fpage>
<lpage>1512</lpage>
<pub-id pub-id-type="pmid">19933107</pub-id>
</element-citation>
</ref>
<ref id="R23">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Moscou</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Bogdanove</surname>
<given-names>AJ</given-names>
</name>
<article-title>A simple cipher governs DNA recognition by TAL effectors.</article-title>
<source/>Science
          <year>2009</year>
<volume>326</volume>
<issue>5959</issue>
<fpage>1501</fpage>
<pub-id pub-id-type="pmid">19933106</pub-id>
</element-citation>
</ref>
<ref id="R24">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>DeFrancesco</surname>
<given-names>L</given-names>
</name>
<article-title>Move over ZFNs.</article-title>
<source/>Nat Biotech
          <year>2011</year>
<volume>29</volume>
<issue>8</issue>
<fpage>681</fpage>
<lpage>684</lpage>
</element-citation>
</ref>
<ref id="R25">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Naitou</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nakanishi</surname>
<given-names>T</given-names>
</name>
<etal></etal>
<article-title>Heterodimeric TALENs induce targeted heritable mutations in the crustacean Daphnia magna.</article-title>
<source/>Biol Open
          <year>2015</year>
<volume>4</volume>
<issue>3</issue>
<fpage>BIO20149738-369</fpage>
</element-citation>
</ref>
<ref id="R26">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Kim</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bae</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J</given-names>
</name>
<etal></etal>
<article-title>Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells.</article-title>
<source/>Nat Meth
          <year>2015</year>
<volume>12</volume>
<issue>3</issue>
<fpage>237</fpage>
<lpage>243</lpage>
</element-citation>
</ref>
<ref id="R27">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Tsai</surname>
<given-names>SQ</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>NT</given-names>
</name>
<etal></etal>
<article-title>GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases.</article-title>
<source/>Nat Biotech
          <year>2014</year>
<volume>33</volume>
<issue>2</issue>
<fpage>187</fpage>
<lpage>197</lpage>
</element-citation>
</ref>
<ref id="R28">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>O'Geen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Henry</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Bhakta</surname>
<given-names>MS</given-names>
</name>
<etal></etal>
<article-title>A genome-wide analysis of Cas9 binding specificity using ChIP-seq and targeted sequence capture.</article-title>
<source/>Nucleic Acids Res
          <year>2015</year>
<volume>43</volume>
<issue>6</issue>
<fpage>gkv137-3404</fpage>
</element-citation>
</ref>
<ref id="R29">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Ding</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Regan</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
<article-title>Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs.</article-title>
<source/>Cell Stem Cell
          <year>2013</year>
<volume>12</volume>
<issue>4</issue>
<fpage>393</fpage>
<lpage>394</lpage>
<pub-id pub-id-type="pmid">23561441</pub-id>
</element-citation>
</ref>
<ref id="R30">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Barrangou</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fremaux</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Deveau</surname>
<given-names>H</given-names>
</name>
<etal></etal>
<article-title>CRISPR provides acquired resistance against viruses in prokaryotes.</article-title>
<source/>Science
          <year>2007</year>
<volume>315</volume>
<issue>5819</issue>
<fpage>1709</fpage>
<lpage>1712</lpage>
<pub-id pub-id-type="pmid">17379808</pub-id>
</element-citation>
</ref>
<ref id="R31">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Cong</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ran</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>D</given-names>
</name>
<etal></etal>
<article-title>Multiplex genome engineering using CRISPR/Cas systems.</article-title>
<source/>Science
          <year>2013</year>
<volume>339</volume>
<issue>6121</issue>
<fpage>819</fpage>
<lpage>823</lpage>
<pub-id pub-id-type="pmid">23287718</pub-id>
</element-citation>
</ref>
<ref id="R32">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Sternberg</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Redding</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jinek</surname>
<given-names>M</given-names>
</name>
<etal></etal>
<article-title>DNA interrogation by the CRISPR RNA-guided endonuclease Cas9.</article-title>
<source/>Nature
          <year>2014</year>
<volume>507</volume>
<issue>7490</issue>
<fpage>62</fpage>
<lpage>67</lpage>
<pub-id pub-id-type="pmid">24476820</pub-id>
</element-citation>
</ref>
<ref id="R33">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Doudna</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Charpentier</surname>
<given-names>E</given-names>
</name>
<article-title>The new frontier of genome engineering with CRISPR-Cas9.</article-title>
<source/>Science
          <year>2014</year>
<volume>346</volume>
<issue>6213</issue>
<fpage>1258096-6</fpage>
<pub-id pub-id-type="pmid">25430774</pub-id>
</element-citation>
</ref>
<ref id="R34">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Gersbach</surname>
<given-names>CA</given-names>
</name>
<article-title>Genome engineering: the next genomic revolution.</article-title>
<source/>Nat Meth
          <year>2014</year>
<volume>11</volume>
<issue>10</issue>
<fpage>1009</fpage>
<lpage>1011</lpage>
</element-citation>
</ref>
<ref id="R35">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Ran</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Cong</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>WX</given-names>
</name>
<etal></etal>
<article-title>In vivo genome editing using Staphylococcus aureus Cas9.</article-title>
<source/>Nature
          <year>2015</year>
<volume>520</volume>
<issue>7546</issue>
<fpage>186</fpage>
<lpage>191</lpage>
<pub-id pub-id-type="pmid">25830891</pub-id>
</element-citation>
</ref>
<ref id="R36">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Chen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sanjana</surname>
<given-names>NE</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>K</given-names>
</name>
<etal></etal>
<article-title>Genome-wide CRISPR Screen in a Mouse Model of Tumor Growth and Metastasis.</article-title>
<source/>Cell
          <year>2015</year>
<volume>160</volume>
<issue>6</issue>
<fpage>1246</fpage>
<lpage>1260</lpage>
<pub-id pub-id-type="pmid">25748654</pub-id>
</element-citation>
</ref>
<ref id="R37">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Harrison</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Jenkins</surname>
<given-names>BV</given-names>
</name>
<name>
<surname>O'Connor-Giles</surname>
<given-names>KM</given-names>
</name>
<etal></etal>
<article-title>A CRISPR view of development.</article-title>
<source/>Genes Dev
          <year>2014</year>
<volume>28</volume>
<issue>17</issue>
<fpage>1859</fpage>
<lpage>1872</lpage>
<pub-id pub-id-type="pmid">25184674</pub-id>
</element-citation>
</ref>
<ref id="R38">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Gasiunas</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Barrangou</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Horvath</surname>
<given-names>P</given-names>
</name>
<etal></etal>
<article-title>Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria.</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2012</year>
<volume>109</volume>
<issue>39</issue>
<fpage>E2579</fpage>
<lpage>E2586</lpage>
<pub-id pub-id-type="pmid">22949671</pub-id>
</element-citation>
</ref>
<ref id="R39">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Jinek</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chylinski</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fonfara</surname>
<given-names>I</given-names>
</name>
<etal></etal>
<article-title>A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.</article-title>
<source/>Science
          <year>2012</year>
<volume>337</volume>
<issue>6096</issue>
<fpage>816</fpage>
<lpage>821</lpage>
<pub-id pub-id-type="pmid">22745249</pub-id>
</element-citation>
</ref>
<ref id="R40">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Garriga-Canut</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Agustín-Pavón</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Herrmann</surname>
<given-names>F</given-names>
</name>
<etal></etal>
<article-title>Synthetic zinc finger repressors reduce mutant huntingtin expression in the brain of R6/2 mice.</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2012</year>
<volume>109</volume>
<issue>45</issue>
<fpage>E3136</fpage>
<lpage>E3145</lpage>
<pub-id pub-id-type="pmid">23054839</pub-id>
</element-citation>
</ref>
<ref id="R41">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Gilbert</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Larson</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Morsut</surname>
<given-names>L</given-names>
</name>
<etal></etal>
<article-title>CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes.</article-title>
<source/>Cell
          <year>2013</year>
<volume>154</volume>
<issue>2</issue>
<fpage>442</fpage>
<lpage>451</lpage>
<pub-id pub-id-type="pmid">23849981</pub-id>
</element-citation>
</ref>
<ref id="R42">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Chavez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Scheiman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vora</surname>
<given-names>S</given-names>
</name>
<etal></etal>
<article-title>Highly efficient Cas9-mediated transcriptional programming.</article-title>
<source/>Nat Meth
          <year>2015</year>
<volume>12</volume>
<issue>4</issue>
<fpage>326</fpage>
<lpage>328</lpage>
</element-citation>
</ref>
<ref id="R43">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Snowden</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Gregory</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Case</surname>
<given-names>CC</given-names>
</name>
<etal></etal>
<article-title>Gene-specific targeting of H3K9 methylation is sufficient for initiating repression in vivo.</article-title>
<source/>Curr Biol
          <year>2002</year>
<volume>12</volume>
<issue>24</issue>
<fpage>2159</fpage>
<lpage>2166</lpage>
<pub-id pub-id-type="pmid">12498693</pub-id>
</element-citation>
</ref>
<ref id="R44">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Nguyen</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Miyaoka</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gilbert</surname>
<given-names>LA</given-names>
</name>
<etal></etal>
<article-title>Ligand-binding domains of nuclear receptors facilitate tight control of split CRISPR activity.</article-title>
<source/>Nat Commun
          <year>2016</year>
<volume>7</volume>
<fpage>1</fpage>
<lpage>10</lpage>
</element-citation>
</ref>
<ref id="R45">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Zetsche</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Volz</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F</given-names>
</name>
<etal></etal>
<article-title> split-Cas9 architecture for inducible genome editing and transcription modulation.</article-title>
<source/>Nat Biotechnol
          <year>2015</year>
<volume>33</volume>
<issue>2</issue>
<fpage>139</fpage>
<lpage>142</lpage>
<pub-id pub-id-type="pmid">25643054</pub-id>
</element-citation>
</ref>
<ref id="R46">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Polstein</surname>
<given-names>LR</given-names>
</name>
<name>
<surname>Gersbach</surname>
<given-names>CA</given-names>
</name>
<article-title>A light-inducible CRISPR-Cas9 system for control of endogenous gene activation.</article-title>
<source/>Nat Chem Biol
          <year>2015</year>
<volume>11</volume>
<issue>3</issue>
<fpage>198</fpage>
<lpage>200</lpage>
<pub-id pub-id-type="pmid">25664691</pub-id>
</element-citation>
</ref>
<ref id="R47">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Paquet</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kwart</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>A</given-names>
</name>
<etal></etal>
<article-title>Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9.</article-title>
<source/>Nature
          <year>2016</year>
<volume>533</volume>
<issue>7601</issue>
<fpage>125</fpage>
<lpage>129</lpage>
<pub-id pub-id-type="pmid">27120160</pub-id>
</element-citation>
</ref>
<ref id="R48">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Wu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Kriz</surname>
<given-names>AJ</given-names>
</name>
<etal></etal>
<article-title>Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells.</article-title>
<source/>Nat Biotechnol
          <year>2014</year>
<volume>32</volume>
<issue>7</issue>
<fpage>1</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">24406907</pub-id>
</element-citation>
</ref>
<ref id="R49">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Kuscu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Arslan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>R</given-names>
</name>
<etal></etal>
<article-title>Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease.</article-title>
<source/>Nat Biotechnol
          <year>2014</year>
<volume>32</volume>
<issue>7</issue>
<fpage>677</fpage>
<lpage>683</lpage>
<pub-id pub-id-type="pmid">24837660</pub-id>
</element-citation>
</ref>
<ref id="R50">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Perez-Pinera</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kocak</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Vockley</surname>
<given-names>CM</given-names>
</name>
<etal></etal>
<article-title>RNA-guided gene activation by CRISPR-Cas9–based transcription factors.</article-title>
<source/>Nat Meth
          <year>2013</year>
<volume>10</volume>
<issue>10</issue>
<fpage>973</fpage>
<lpage>976</lpage>
</element-citation>
</ref>
<ref id="R51">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Boel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Steyaert</surname>
<given-names>W</given-names>
</name>
<name>
<surname>De Rocker</surname>
<given-names>N</given-names>
</name>
<etal></etal>
<article-title>BATCH-GE: Batch analysis of Next-Generation Sequencing data for genome editing assessment.</article-title>
<source/>Sci Rep
          <year>2016</year>
<volume>6</volume>
<fpage>30330</fpage>
<lpage>30339</lpage>
<pub-id pub-id-type="pmid">27461955</pub-id>
</element-citation>
</ref>
<ref id="R52">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Zhang</surname>
<given-names>J-P</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X-L</given-names>
</name>
<name>
<surname>Neises</surname>
<given-names>A</given-names>
</name>
<etal></etal>
<article-title>Different Effects of sgRNA Length on CRISPR-mediated Gene Knockout Efficiency.</article-title>
<source/>Sci Rep
          <year>2016</year>
<volume>6</volume>
<fpage>28566</fpage>
<pub-id pub-id-type="pmid">27338021</pub-id>
</element-citation>
</ref>
<ref id="R53">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Stella</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Montoya</surname>
<given-names>G</given-names>
</name>
<article-title>The genome editing revolution: A CRISPR-Cas TALE off-target story.</article-title>
<source/>BioEssays
          <year>2016</year>
<volume>38</volume>
<issue>S1</issue>
<fpage>S4</fpage>
<lpage>S13</lpage>
<pub-id pub-id-type="pmid">27417121</pub-id>
</element-citation>
</ref>
<ref id="R54">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Kanchiswamy</surname>
<given-names>CN</given-names>
</name>
<name>
<surname>Maffei</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Malnoy</surname>
<given-names>M</given-names>
</name>
<etal></etal>
<article-title>Fine-Tuning Next-Generation Genome Editing Tools.</article-title>
<source/>Trends Biotechnol
          <year>2016</year>
<volume>34</volume>
<issue>7</issue>
<fpage>562</fpage>
<lpage>574</lpage>
<pub-id pub-id-type="pmid">27167723</pub-id>
</element-citation>
</ref>
<ref id="R55">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shivalila</surname>
<given-names>CS</given-names>
</name>
<etal></etal>
<article-title>One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering.</article-title>
<source/>Cell
          <year>2013</year>
<volume>153</volume>
<issue>4</issue>
<fpage>910</fpage>
<lpage>918</lpage>
<pub-id pub-id-type="pmid">23643243</pub-id>
</element-citation>
</ref>
<ref id="R56">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Li</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
<article-title>Heritable gene targeting in the mouse and rat using a CRISPR-Cas system.</article-title>
<source/>Nat Biotechnol
          <year>2013</year>
<volume>31</volume>
<issue>8</issue>
<fpage>681</fpage>
<lpage>683</lpage>
<pub-id pub-id-type="pmid">23929336</pub-id>
</element-citation>
</ref>
<ref id="R57">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Straub</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Granger</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Saulnier</surname>
<given-names>JL</given-names>
</name>
<etal></etal>
<article-title>CRISPR/Cas9-mediated gene knock-down in post-mitotic neurons.</article-title>
<source/>PLoS ONe
          <year>2014</year>
<volume>9</volume>
<issue>8</issue>
<fpage>e105584</fpage>
<pub-id pub-id-type="pmid">25140704</pub-id>
</element-citation>
</ref>
<ref id="R58">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Incontro</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Asensio</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Edwards</surname>
<given-names>RH</given-names>
</name>
<etal></etal>
<article-title>Efficient, complete deletion of synaptic proteins using CRISPR.</article-title>
<source/>Neuron
          <year>2014</year>
<volume>83</volume>
<issue>5</issue>
<fpage>1051</fpage>
<lpage>1057</lpage>
<pub-id pub-id-type="pmid">25155957</pub-id>
</element-citation>
</ref>
<ref id="R59">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Swiech</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Heidenreich</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Banerjee</surname>
<given-names>A</given-names>
</name>
<etal></etal>
<article-title>In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9.</article-title>
<source/>Nat Biotechnol
          <year>2015</year>
<volume>33</volume>
<issue>1</issue>
<fpage>102</fpage>
<lpage>106</lpage>
<pub-id pub-id-type="pmid">25326897</pub-id>
</element-citation>
</ref>
<ref id="R60">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Brzezinski</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Lamba</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Reh</surname>
<given-names>TA</given-names>
</name>
<etal></etal>
<article-title>Blimp1 controls photoreceptor versus bipolar cell fate choice during retinal development.</article-title>
<source/>Development
          <year>2010</year>
<volume>137</volume>
<issue>4</issue>
<fpage>619</fpage>
<lpage>629</lpage>
<pub-id pub-id-type="pmid">20110327</pub-id>
</element-citation>
</ref>
<ref id="R61">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Jia</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>ECT</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>L</given-names>
</name>
<etal></etal>
<article-title>Retinoid-related orphan nuclear receptor RORbeta is an early-acting factor in rod photoreceptor development.</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2009</year>
<volume>106</volume>
<issue>41</issue>
<fpage>17534</fpage>
<lpage>17539</lpage>
<pub-id pub-id-type="pmid">19805139</pub-id>
</element-citation>
</ref>
<ref id="R62">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Cherry</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bormuth</surname>
<given-names>I</given-names>
</name>
<etal></etal>
<article-title>NeuroD factors regulate cell fate and neurite stratification in the developing retina.</article-title>
<source/>J Neurosci
          <year>2011</year>
<volume>31</volume>
<issue>20</issue>
<fpage>7365</fpage>
<lpage>7379</lpage>
<pub-id pub-id-type="pmid">21593321</pub-id>
</element-citation>
</ref>
<ref id="R63">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Turner</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Cepko</surname>
<given-names>CL</given-names>
</name>
<article-title>A common progenitor for neurons and glia persists in rat retina late in development.</article-title>
<source/>Nature
          <year>1987</year>
<volume>328</volume>
<issue>6126</issue>
<fpage>131</fpage>
<lpage>136</lpage>
<pub-id pub-id-type="pmid">3600789</pub-id>
</element-citation>
</ref>
<ref id="R64">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sengel</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Emerson</surname>
<given-names>MM</given-names>
</name>
<etal></etal>
<article-title>A gene regulatory network controls the binary fate decision of rod and bipolar cells in the vertebrate retina.</article-title>
<source/>Dev Cell
          <year>2014</year>
<volume>30</volume>
<issue>5</issue>
<fpage>513</fpage>
<lpage>527</lpage>
<pub-id pub-id-type="pmid">25155555</pub-id>
</element-citation>
</ref>
<ref id="R65">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Sagai</surname>
<given-names>T</given-names>
</name>
<article-title>Elimination of a long-range cis-regulatory module causes complete loss of limb-specific Shh expression and truncation of the mouse limb.</article-title>
<source/>Development
          <year>2005</year>
<volume>132</volume>
<issue>4</issue>
<fpage>797</fpage>
<lpage>803</lpage>
<pub-id pub-id-type="pmid">15677727</pub-id>
</element-citation>
</ref>
<ref id="R66">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Prescott</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Srinivasan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Marchetto</surname>
<given-names>MC</given-names>
</name>
<etal></etal>
<article-title>Enhancer Divergence and cis-Regulatory Evolution in the Human and Chimp Neural Crest.</article-title>
<source/>Cell
          <year>2015</year>
<volume>163</volume>
<issue>1</issue>
<fpage>68</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="pmid">26365491</pub-id>
</element-citation>
</ref>
<ref id="R67">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Villar</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Berthelot</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Aldridge</surname>
<given-names>S</given-names>
</name>
<etal></etal>
<article-title>Enhancer Evolution across 20 Mammalian Species.</article-title>
<source/>Cell
          <year>2015</year>
<volume>160</volume>
<issue>3</issue>
<fpage>554</fpage>
<lpage>566</lpage>
<pub-id pub-id-type="pmid">25635462</pub-id>
</element-citation>
</ref>
<ref id="R68">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Smith</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Shilatifard</surname>
<given-names>A</given-names>
</name>
<article-title>Enhancer biology and enhanceropathies.</article-title>
<source/>Nat Struct Mol Biol
          <year>2014</year>
<volume>21</volume>
<issue>3</issue>
<fpage>210</fpage>
<lpage>219</lpage>
<pub-id pub-id-type="pmid">24599251</pub-id>
</element-citation>
</ref>
<ref id="R69">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Ghiasvand</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Rudolph</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Mashayekhi</surname>
<given-names>M</given-names>
</name>
<etal></etal>
<article-title>Deletion of a remote enhancer near ATOH7 disrupts retinal neurogenesis, causing NCRNA disease.</article-title>
<source/>Nature
          <year>2011</year>
<volume>14</volume>
<issue>5</issue>
<fpage>578</fpage>
<lpage>586</lpage>
</element-citation>
</ref>
<ref id="R70">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Jeong</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Leskow</surname>
<given-names>FC</given-names>
</name>
<name>
<surname>El-Jaick</surname>
<given-names>K</given-names>
</name>
<etal></etal>
<article-title>Regulation of a remote Shh forebrain enhancer by the Six3 homeoprotein.</article-title>
<source/>Nat Genet
          <year>2008</year>
<volume>40</volume>
<issue>11</issue>
<fpage>1348</fpage>
<lpage>1353</lpage>
<pub-id pub-id-type="pmid">18836447</pub-id>
</element-citation>
</ref>
<ref id="R71">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Lettice</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Daniels</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sweeney</surname>
<given-names>E</given-names>
</name>
<etal></etal>
<article-title>Enhancer-adoption as a mechanism of human developmental disease.</article-title>
<source/>Hum Mutat
          <year>2011</year>
<volume>32</volume>
<issue>12</issue>
<fpage>1492</fpage>
<lpage>1499</lpage>
<pub-id pub-id-type="pmid">21948517</pub-id>
</element-citation>
</ref>
<ref id="R72">
<element-citation publication-format="print" publication-type="journal">
<collab>Schizophrenia Working Group of the Psychiatric Genomics Consortium.</collab>
<article-title>Biological insights from 108 schizophrenia-associated genetic loci.</article-title>
<source/>Nature
          <year>2014</year>
<volume>511</volume>
<issue>7510</issue>
<fpage>421</fpage>
<lpage>427</lpage>
<pub-id pub-id-type="pmid">25056061</pub-id>
</element-citation>
</ref>
<ref id="R73">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Kilpinen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Waszak</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Gschwind</surname>
<given-names>AR</given-names>
</name>
<etal></etal>
<article-title>Coordinated effects of sequence variation on DNA binding, chromatin structure, and transcription.</article-title>
<source/>Science
          <year>2013</year>
<volume>342</volume>
<issue>6159</issue>
<fpage>744</fpage>
<lpage>747</lpage>
<pub-id pub-id-type="pmid">24136355</pub-id>
</element-citation>
</ref>
<ref id="R74">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>McVicker</surname>
<given-names>G</given-names>
</name>
<name>
<surname>van de Geijn</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Degner</surname>
<given-names>JF</given-names>
</name>
<etal></etal>
<article-title>Identification of genetic variants that affect histone modifications in human cells.</article-title>
<source/>Science
          <year>2013</year>
<volume>342</volume>
<issue>6159</issue>
<fpage>747</fpage>
<lpage>749</lpage>
<pub-id pub-id-type="pmid">24136359</pub-id>
</element-citation>
</ref>
<ref id="R75">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Soldner</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Stelzer</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shivalila</surname>
<given-names>CS</given-names>
</name>
<etal></etal>
<article-title>Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression.</article-title>
<source/>Nature
          <year>2016</year>
<volume>533</volume>
<issue>7601</issue>
<fpage>95</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="pmid">27096366</pub-id>
</element-citation>
</ref>
<ref id="R76">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Murlidharan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sakamoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>L</given-names>
</name>
<etal></etal>
<article-title>CNS-restricted Transduction and CRISPR/Cas9-mediated Gene Deletion with an Engineered AAV Vector.</article-title>
<source/>Mol Ther Nucleic Acids
          <year>2016</year>
<volume>5</volume>
<issue>7</issue>
<fpage>e338</fpage>
<pub-id pub-id-type="pmid">27434683</pub-id>
</element-citation>
</ref>
<ref id="R77">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Hung</surname>
<given-names>SSC</given-names>
</name>
<name>
<surname>Chrysostomou</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F</given-names>
</name>
<etal></etal>
<article-title>AAV-Mediated CRISPR/Cas Gene Editing of Retinal Cells In Vivo.</article-title>
<source/>Invest Ophthalmol Vis Sci
          <year>2016</year>
<volume>57</volume>
<issue>7</issue>
<fpage>3470</fpage>
<lpage>3476</lpage>
<pub-id pub-id-type="pmid">27367513</pub-id>
</element-citation>
</ref>
<ref id="R78">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Meyer</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Benkusky</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Pike</surname>
<given-names>JW</given-names>
</name>
<article-title>Selective Distal Enhancer Control of the Mmp13 Gene Identified through Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) Genomic Deletions.</article-title>
<source/>J Biol Chem
          <year>2015</year>
<volume>290</volume>
<issue>17</issue>
<fpage>11093</fpage>
<lpage>11107</lpage>
<pub-id pub-id-type="pmid">25773540</pub-id>
</element-citation>
</ref>
<ref id="R79">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Canver</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Sher</surname>
<given-names>F</given-names>
</name>
<etal></etal>
<article-title>BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis.</article-title>
<source/>Nature
          <year>2015</year>
<volume>527</volume>
<issue>7577</issue>
<fpage>192</fpage>
<lpage>197</lpage>
<pub-id pub-id-type="pmid">26375006</pub-id>
</element-citation>
</ref>
<ref id="R80">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Diao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
<article-title>A new class of temporarily phenotypic enhancers identified by CRISPR/Cas9-mediated genetic screening.</article-title>
<source/>Genome Res
          <year>2016</year>
<volume>26</volume>
<issue>3</issue>
<fpage>397</fpage>
<lpage>405</lpage>
<pub-id pub-id-type="pmid">26813977</pub-id>
</element-citation>
</ref>
<ref id="R81">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Korkmaz</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lopes</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ugalde</surname>
<given-names>AP</given-names>
</name>
<etal></etal>
<article-title>Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9.</article-title>
<source/>Nat Biotechnol
          <year>2016</year>
<volume>34</volume>
<issue>2</issue>
<fpage>192</fpage>
<lpage>198</lpage>
<pub-id pub-id-type="pmid">26751173</pub-id>
</element-citation>
</ref>
<ref id="R82">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Hrvatin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>F</given-names>
</name>
<name>
<surname>O'Donnell</surname>
<given-names>CW</given-names>
</name>
<etal></etal>
<article-title>MARIS: Method for Analyzing RNA following Intracellular Sorting.</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<issue>3</issue>
<fpage>e89459-6</fpage>
<pub-id pub-id-type="pmid">24594682</pub-id>
</element-citation>
</ref>
<ref id="R83">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Deal</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Henikoff</surname>
<given-names>S</given-names>
</name>
<article-title>The INTACT method for cell type-specific gene expression and chromatin profiling in Arabidopsis thaliana.</article-title>
<source/>Nat Protoc
          <year>2010</year>
<volume>6</volume>
<issue>1</issue>
<fpage>56</fpage>
<lpage>68</lpage>
<pub-id pub-id-type="pmid">21212783</pub-id>
</element-citation>
</ref>
<ref id="R84">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Belton</surname>
<given-names>J-M</given-names>
</name>
<name>
<surname>McCord</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Gibcus</surname>
<given-names>JH</given-names>
</name>
<etal></etal>
<article-title>Hi-C: A comprehensive technique to capture the conformation of genomes.</article-title>
<source/>Methods
          <year>2012</year>
<volume>58</volume>
<issue>3</issue>
<fpage>268</fpage>
<lpage>276</lpage>
<pub-id pub-id-type="pmid">22652625</pub-id>
</element-citation>
</ref>
<ref id="R85">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Bolland</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>King</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Reik</surname>
<given-names>W</given-names>
</name>
<etal></etal>
<article-title>Robust 3D DNA FISH using directly labeled probes.</article-title>
<source/>J Vis Exp
          <year>2013</year>
<volume>78</volume>
<fpage>e50587-7</fpage>
</element-citation>
</ref>
<ref id="R86">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Bartman</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Hsiung</surname>
<given-names>CCS</given-names>
</name>
<etal></etal>
<article-title>Enhancer Regulation of Transcriptional Bursting Parameters Revealed by Forced Chromatin Looping.</article-title>
<source/>Mol Cell
          <year>2016</year>
<volume>62</volume>
<issue>2</issue>
<fpage>237</fpage>
<lpage>247</lpage>
<pub-id pub-id-type="pmid">27067601</pub-id>
</element-citation>
</ref>
<ref id="R87">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Shao</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>H</given-names>
</name>
<etal></etal>
<article-title>Long-term dual-color tracking of genomic loci by modified sgRNAs of the CRISPR/Cas9 system.</article-title>
<source/>Nucleic Acids Res
          <year>2016</year>
<volume>44</volume>
<issue>9</issue>
<fpage>e86</fpage>
<pub-id pub-id-type="pmid">26850639</pub-id>
</element-citation>
</ref>
<ref id="R88">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Ma</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tu</surname>
<given-names>L-C</given-names>
</name>
<name>
<surname>Naseri</surname>
<given-names>A</given-names>
</name>
<etal></etal>
<article-title>Multiplexed labeling of genomic loci with dCas9 and engineered sgRNAs using CRISPRainbow.</article-title>
<source/>Nat Biotechnol
          <year>2016</year>
<volume>34</volume>
<issue>5</issue>
<fpage>528</fpage>
<lpage>530</lpage>
<pub-id pub-id-type="pmid">27088723</pub-id>
</element-citation>
</ref>
<ref id="R89">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Femino</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Fay</surname>
<given-names>FS</given-names>
</name>
<name>
<surname>Fogarty</surname>
<given-names>K</given-names>
</name>
<etal></etal>
<article-title>Visualization of single RNA transcripts in situ.</article-title>
<source/>Science
          <year>1998</year>
<volume>280</volume>
<issue>5363</issue>
<fpage>585</fpage>
<lpage>590</lpage>
<pub-id pub-id-type="pmid">9554849</pub-id>
</element-citation>
</ref>
<ref id="R90">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Mueller</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Senecal</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tantale</surname>
<given-names>K</given-names>
</name>
<etal></etal>
<article-title>FISH-quant: automatic counting of transcripts in 3D FISH images.</article-title>
<source/>Nat Methods
          <year>2013</year>
<volume>10</volume>
<issue>4</issue>
<fpage>277</fpage>
<lpage>278</lpage>
<pub-id pub-id-type="pmid">23538861</pub-id>
</element-citation>
</ref>
<ref id="R91">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Nelles</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>O'Connell</surname>
<given-names>MR</given-names>
</name>
<etal></etal>
<article-title>Programmable RNA Tracking in Live Cells with CRISPR/Cas9.</article-title>
<source/>Cell
          <year>2016</year>
<volume>165</volume>
<issue>2</issue>
<fpage>488</fpage>
<lpage>496</lpage>
<pub-id pub-id-type="pmid">26997482</pub-id>
</element-citation>
</ref>
<ref id="R92">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Mardinly</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Spiegel</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Patrizi</surname>
<given-names>A</given-names>
</name>
<etal></etal>
<article-title>Sensory experience regulates cortical inhibition by inducing IGF1 in VIP neurons.</article-title>
<source/>Nature
          <year>2016</year>
<volume>531</volume>
<issue>7594</issue>
<fpage>371</fpage>
<lpage>375</lpage>
<pub-id pub-id-type="pmid">26958833</pub-id>
</element-citation>
</ref>
<ref id="R93">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Cosker</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Fenstermacher</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Pazyra-Murphy</surname>
<given-names>MF</given-names>
</name>
<etal></etal>
<article-title>The RNA-binding protein SFPQ orchestrates an RNA regulon to promote axon viability.</article-title>
<source/>Nat Neurosci
          <year>2016</year>
<volume>19</volume>
<issue>5</issue>
<fpage>690</fpage>
<lpage>696</lpage>
<pub-id pub-id-type="pmid">27019013</pub-id>
</element-citation>
</ref>
<ref id="R94">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>J-H</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F</given-names>
</name>
<etal></etal>
<article-title>An RNA-aptamer-based two-color CRISPR labeling system.</article-title>
<source/>Sci Rep
          <year>2016</year>
<volume>6</volume>
<fpage>1</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">28442746</pub-id>
</element-citation>
</ref>
<ref id="R95">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Li</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Barish</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Okuwa</surname>
<given-names>S</given-names>
</name>
<etal></etal>
<article-title>Examination of Endogenous Rotund Expression and Function in Developing Drosophila Olfactory System Using CRISPR-Cas9-Mediated Protein Tagging.</article-title>
<source/>G3 (Bethesda)
          <year>2015</year>
<volume>5</volume>
<issue>12</issue>
<fpage>2809</fpage>
<lpage>2016</lpage>
<pub-id pub-id-type="pmid">26497147</pub-id>
</element-citation>
</ref>
<ref id="R96">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Koles</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yeh</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Rodal</surname>
<given-names>AA</given-names>
</name>
<etal></etal>
<article-title>Tissue-specific tagging of endogenous loci in Drosophila melanogaster.</article-title>
<source/>Biol Open
          <year>2015</year>
<volume>5</volume>
<issue>1</issue>
<fpage>83</fpage>
<lpage>89</lpage>
<pub-id pub-id-type="pmid">26700726</pub-id>
</element-citation>
</ref>
<ref id="R97">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Mikuni</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nishiyama</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
<article-title>High-Throughput, High-Resolution Mapping of Protein Localization in Mammalian Brain by In Vivo Genome Editing.</article-title>
<source/>Cell
          <year>2016</year>
<volume>165</volume>
<issue>7</issue>
<fpage>1803</fpage>
<lpage>1817</lpage>
<pub-id pub-id-type="pmid">27180908</pub-id>
</element-citation>
</ref>
<ref id="R98">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Qi</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Larson</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Gilbert</surname>
<given-names>LA</given-names>
</name>
<etal></etal>
<article-title>Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression.</article-title>
<source/>Cell
          <year>2013</year>
<volume>152</volume>
<issue>5</issue>
<fpage>1173</fpage>
<lpage>1183</lpage>
<pub-id pub-id-type="pmid">23452860</pub-id>
</element-citation>
</ref>
<ref id="R99">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Larson</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Gilbert</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<etal></etal>
<article-title>CRISPR interference (CRISPRi) for sequence-specific control of gene expression.</article-title>
<source/>Nat Protoc
          <year>2013</year>
<volume>8</volume>
<issue>11</issue>
<fpage>2180</fpage>
<lpage>2196</lpage>
<pub-id pub-id-type="pmid">24136345</pub-id>
</element-citation>
</ref>
<ref id="R100">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Maeder</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Linder</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Cascio</surname>
<given-names>VM</given-names>
</name>
<etal></etal>
<article-title>CRISPR RNA-guided activation of endogenous human genes.</article-title>
<source/>Nat Meth
          <year>2013</year>
<volume>10</volume>
<issue>10</issue>
<fpage>977</fpage>
<lpage>979</lpage>
</element-citation>
</ref>
<ref id="R101">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Mali</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Aach</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Stranges</surname>
<given-names>PB</given-names>
</name>
<etal></etal>
<article-title>CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering.</article-title>
<source/>Nat Biotech
          <year>2013</year>
<volume>31</volume>
<issue>9</issue>
<fpage>833</fpage>
<lpage>838</lpage>
</element-citation>
</ref>
<ref id="R102">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Konermann</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Brigham</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Trevino</surname>
<given-names>AE</given-names>
</name>
<etal></etal>
<article-title>Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex.</article-title>
<source/>Nature
          <year>2015</year>
<volume>517</volume>
<issue>7536</issue>
<fpage>583</fpage>
<lpage>588</lpage>
<pub-id pub-id-type="pmid">25494202</pub-id>
</element-citation>
</ref>
<ref id="R103">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Saayman</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Lazar</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>TA</given-names>
</name>
<etal></etal>
<article-title>Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator Complex.</article-title>
<source/>Mol Ther
          <year>2015</year>
<volume>24</volume>
<issue>3</issue>
<fpage>488</fpage>
<lpage>498</lpage>
<pub-id pub-id-type="pmid">26581162</pub-id>
</element-citation>
</ref>
<ref id="R104">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Gao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Tsang</surname>
<given-names>JCH</given-names>
</name>
<name>
<surname>Gaba</surname>
<given-names>F</given-names>
</name>
<etal></etal>
<article-title>Comparison of TALE designer transcription factors and the CRISPR/dCas9 in regulation of gene expression by targeting enhancers.</article-title>
<source/>Nucleic Acids Res
          <year>2014</year>
<volume>42</volume>
<issue>20</issue>
<fpage>e155</fpage>
<pub-id pub-id-type="pmid">25223790</pub-id>
</element-citation>
</ref>
<ref id="R105">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Chavez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tuttle</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pruitt</surname>
<given-names>BW</given-names>
</name>
<etal></etal>
<article-title>Comparison of Cas9 activators in multiple species.</article-title>
<source/>Nat Meth
          <year>2016</year>
<volume>13</volume>
<issue>7</issue>
<fpage>563</fpage>
<lpage>567</lpage>
</element-citation>
</ref>
<ref id="R106">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Polstein</surname>
<given-names>LR</given-names>
</name>
<name>
<surname>Perez-Pinera</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kocak</surname>
<given-names>DD</given-names>
</name>
<etal></etal>
<article-title>Genome-wide specificity of DNA binding, gene regulation, and chromatin remodeling by TALE- and CRISPR/Cas9-based transcriptional activators.</article-title>
<source/>Genome Res
          <year>2015</year>
<volume>25</volume>
<issue>8</issue>
<fpage>1158</fpage>
<lpage>1159</lpage>
<pub-id pub-id-type="pmid">26025803</pub-id>
</element-citation>
</ref>
<ref id="R107">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>McLean</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Bristor</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hiller</surname>
<given-names>M</given-names>
</name>
<etal></etal>
<article-title>GREAT improves functional interpretation of cis-regulatory regions.</article-title>
<source/>Nat Biotechnol
          <year>2010</year>
<volume>28</volume>
<issue>5</issue>
<fpage>nbt.1630</fpage>
<lpage>1639</lpage>
</element-citation>
</ref>
<ref id="R108">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Thakore</surname>
<given-names>PI</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Hilton</surname>
<given-names>JB</given-names>
</name>
<etal></etal>
<article-title>Editing the epigenome: technologies for programmable transcription and epigenetic modulation.</article-title>
<source/>Nat Meth
          <year>2016</year>
<volume>13</volume>
<issue>2</issue>
<fpage>127</fpage>
<lpage>137</lpage>
</element-citation>
</ref>
<ref id="R109">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Groner</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Meylan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ciuffi</surname>
<given-names>A</given-names>
</name>
<etal></etal>
<article-title>KRAB-Zinc Finger Proteins and KAP1 Can Mediate Long-Range Transcriptional Repression through Heterochromatin Spreading.</article-title>
<source/>PLoS Genet
          <year>2010</year>
<volume>6</volume>
<issue>3</issue>
<fpage>e1000869-14</fpage>
<pub-id pub-id-type="pmid">20221260</pub-id>
</element-citation>
</ref>
<ref id="R110">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Schultz</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Ayyanathan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Negorev</surname>
<given-names>D</given-names>
</name>
<etal></etal>
<article-title>SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins.</article-title>
<source/>Genes Dev
          <year>2002</year>
<volume>16</volume>
<issue>8</issue>
<fpage>919</fpage>
<lpage>932</lpage>
<pub-id pub-id-type="pmid">11959841</pub-id>
</element-citation>
</ref>
<ref id="R111">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Gilbert</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Horlbeck</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Adamson</surname>
<given-names>B</given-names>
</name>
<etal></etal>
<article-title>Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation.</article-title>
<source/>Cell
          <year>2014</year>
<volume>159</volume>
<issue>3</issue>
<fpage>647</fpage>
<lpage>661</lpage>
<pub-id pub-id-type="pmid">25307932</pub-id>
</element-citation>
</ref>
<ref id="R112">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Joo</surname>
<given-names>J-Y</given-names>
</name>
<name>
<surname>Schaukowitch</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Farbiak</surname>
<given-names>L</given-names>
</name>
<etal></etal>
<article-title>Stimulus-specific combinatorial functionality of neuronal c-fos enhancers.</article-title>
<source/>Nat Neurosci
          <year>2016</year>
<volume>19</volume>
<issue>1</issue>
<fpage>75</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="pmid">26595656</pub-id>
</element-citation>
</ref>
<ref id="R113">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Greenberg</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Ziff</surname>
<given-names>EB</given-names>
</name>
<article-title>Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene.</article-title>
<source/>Nature
          <year>1984</year>
<volume>311</volume>
<issue>5985</issue>
<fpage>433</fpage>
<lpage>438</lpage>
<pub-id pub-id-type="pmid">6090941</pub-id>
</element-citation>
</ref>
<ref id="R114">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Schaukowitch</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Joo</surname>
<given-names>J-Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<etal></etal>
<article-title>Enhancer RNA Facilitates NELF Release from Immediate Early Genes.</article-title>
<source/>Mol Cell
          <year>2014</year>
<volume>56</volume>
<issue>1</issue>
<fpage>29</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="pmid">25263592</pub-id>
</element-citation>
</ref>
<ref id="R115">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Mo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mukamel</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>FP</given-names>
</name>
<etal></etal>
<article-title>Epigenomic Signatures of Neuronal Diversity in the Mammalian Brain.</article-title>
<source/>Neuron
          <year>2015</year>
<volume>86</volume>
<issue>6</issue>
<fpage>1369</fpage>
<lpage>1384</lpage>
<pub-id pub-id-type="pmid">26087164</pub-id>
</element-citation>
</ref>
<ref id="R116">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Mo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>vDavis</surname>
<given-names>FP</given-names>
</name>
<etal></etal>
<article-title>Epigenomic landscapes of retinal rods and cones.</article-title>
<source/>eLife
          <year>2016</year>
<volume>5</volume>
<fpage>e11613-29</fpage>
<pub-id pub-id-type="pmid">26949250</pub-id>
</element-citation>
</ref>
<ref id="R117">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Renthal</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Maze</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Krishnan</surname>
<given-names>V</given-names>
</name>
<etal></etal>
<article-title>Histone Deacetylase 5 Epigenetically Controls Behavioral Adaptations to Chronic Emotional Stimuli.</article-title>
<source/>Neuron
          <year>2007</year>
<volume>56</volume>
<issue>3</issue>
<fpage>517</fpage>
<lpage>529</lpage>
<pub-id pub-id-type="pmid">17988634</pub-id>
</element-citation>
</ref>
<ref id="R118">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Renthal</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Carle</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Maze</surname>
<given-names>I</given-names>
</name>
<etal></etal>
<article-title>Delta FosB mediates epigenetic desensitization of the c-fos gene after chronic amphetamine exposure.</article-title>
<source/>J Neurosci
          <year>2008</year>
<volume>28</volume>
<issue>29</issue>
<fpage>7344</fpage>
<lpage>7349</lpage>
<pub-id pub-id-type="pmid">18632938</pub-id>
</element-citation>
</ref>
<ref id="R119">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Rada-Iglesias</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bajpai</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Swigut</surname>
<given-names>T</given-names>
</name>
<etal></etal>
<article-title>A unique chromatin signature uncovers early developmental enhancers in humans.</article-title>
<source/>Nature
          <year>2011</year>
<volume>470</volume>
<issue>7333</issue>
<fpage>279</fpage>
<lpage>283</lpage>
<pub-id pub-id-type="pmid">21160473</pub-id>
</element-citation>
</ref>
<ref id="R120">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Creyghton</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Welstead</surname>
<given-names>GG</given-names>
</name>
<etal></etal>
<article-title>Histone H3K27ac separates active from poised enhancers and predicts developmental state.</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2010</year>
<volume>107</volume>
<issue>50</issue>
<fpage>21931</fpage>
<lpage>21936</lpage>
<pub-id pub-id-type="pmid">21106759</pub-id>
</element-citation>
</ref>
<ref id="R121">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Ogryzko</surname>
<given-names>VV</given-names>
</name>
<name>
<surname>Schiltz</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Russanova</surname>
<given-names>V</given-names>
</name>
<etal></etal>
<article-title>The transcriptional coactivators p300 and CBP are histone acetyltransferases.</article-title>
<source/>Cell
          <year>1996</year>
<volume>87</volume>
<issue>5</issue>
<fpage>953</fpage>
<lpage>959</lpage>
<pub-id pub-id-type="pmid">8945521</pub-id>
</element-citation>
</ref>
<ref id="R122">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Hilton</surname>
<given-names>IB</given-names>
</name>
<name>
<surname>D'Ippolito</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Vockley</surname>
<given-names>CM</given-names>
</name>
<etal></etal>
<article-title>Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers.</article-title>
<source/>Nat Biotechnol
          <year>2015</year>
<volume>33</volume>
<issue>5</issue>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="pmid">25574611</pub-id>
</element-citation>
</ref>
<ref id="R123">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Konermann</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Brigham</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Trevino</surname>
<given-names>A</given-names>
</name>
<etal></etal>
<article-title>Optical control of mammalian endogenous transcription and epigenetic states.</article-title>
<source/>Nature
          <year>2013</year>
<volume>500</volume>
<issue>7463</issue>
<fpage>472</fpage>
<lpage>476</lpage>
<pub-id pub-id-type="pmid">23877069</pub-id>
</element-citation>
</ref>
<ref id="R124">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Amir</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Van den Veyver</surname>
<given-names>IB</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>M</given-names>
</name>
<etal></etal>
<article-title>Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.</article-title>
<source/>Nat Genet
          <year>1999</year>
<volume>23</volume>
<issue>2</issue>
<fpage>185</fpage>
<lpage>188</lpage>
<pub-id pub-id-type="pmid">10508514</pub-id>
</element-citation>
</ref>
<ref id="R125">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Meehan</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>AP</given-names>
</name>
<article-title>Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA.</article-title>
<source/>Nucleic Acids Res
          <year>1992</year>
<volume>20</volume>
<issue>19</issue>
<fpage>5085</fpage>
<lpage>5092</lpage>
<pub-id pub-id-type="pmid">1408825</pub-id>
</element-citation>
</ref>
<ref id="R126">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Okano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Haber</surname>
<given-names>DA</given-names>
</name>
<etal></etal>
<article-title>DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.</article-title>
<source/>Cell
          <year>1999</year>
<volume>99</volume>
<issue>3</issue>
<fpage>247</fpage>
<lpage>257</lpage>
<pub-id pub-id-type="pmid">10555141</pub-id>
</element-citation>
</ref>
<ref id="R127">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Lister</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mukamel</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Nery</surname>
<given-names>JR</given-names>
</name>
<etal></etal>
<article-title>Global epigenomic reconfiguration during mammalian brain development.</article-title>
<source/>Science
          <year>2013</year>
<volume>341</volume>
<issue>6146</issue>
<fpage>1237905-5</fpage>
<pub-id pub-id-type="pmid">23828890</pub-id>
</element-citation>
</ref>
<ref id="R128">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Cohen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gabel</surname>
<given-names>HW</given-names>
</name>
<name>
<surname>Hemberg</surname>
<given-names>M</given-names>
</name>
<etal></etal>
<article-title>Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function.</article-title>
<source/>Neuron
          <year>2011</year>
<volume>72</volume>
<issue>1</issue>
<fpage>72</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="pmid">21982370</pub-id>
</element-citation>
</ref>
<ref id="R129">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Deng</surname>
<given-names>JV</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<etal></etal>
<article-title>MeCP2 Phosphorylation Limits Psychostimulant-Induced Behavioral and Neuronal Plasticity.</article-title>
<source/>J Neurosci
          <year>2014</year>
<volume>34</volume>
<issue>13</issue>
<fpage>4519</fpage>
<lpage>4527</lpage>
<pub-id pub-id-type="pmid">24671997</pub-id>
</element-citation>
</ref>
<ref id="R130">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Feng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>SL</given-names>
</name>
<etal></etal>
<article-title>Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons.</article-title>
<source/>Nat Neurosci
          <year>2010</year>
<volume>13</volume>
<issue>4</issue>
<fpage>423</fpage>
<lpage>430</lpage>
<pub-id pub-id-type="pmid">20228804</pub-id>
</element-citation>
</ref>
<ref id="R131">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Guo</surname>
<given-names>JU</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>JH</given-names>
</name>
<etal></etal>
<article-title>Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain.</article-title>
<source/>Nat Neurosci
          <year>2013</year>
<volume>17</volume>
<issue>2</issue>
<fpage>215</fpage>
<lpage>222</lpage>
<pub-id pub-id-type="pmid">24362762</pub-id>
</element-citation>
</ref>
<ref id="R132">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Gabel</surname>
<given-names>HW</given-names>
</name>
<name>
<surname>Kinde</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Stroud</surname>
<given-names>H</given-names>
</name>
<etal></etal>
<article-title>Disruption of DNA-methylation-dependent long gene repression in Rett syndrome.</article-title>
<source/>Nature
          <year>2015</year>
<volume>522</volume>
<issue>7554</issue>
<fpage>1</fpage>
<lpage>21</lpage>
</element-citation>
</ref>
<ref id="R133">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Tahiliani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Koh</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
<article-title>Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1.</article-title>
<source/>Science
          <year>2009</year>
<volume>324</volume>
<issue>5929</issue>
<fpage>930</fpage>
<lpage>935</lpage>
<pub-id pub-id-type="pmid">19372391</pub-id>
</element-citation>
</ref>
<ref id="R134">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Kriaucionis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Heintz</surname>
<given-names>N</given-names>
</name>
<article-title>The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain.</article-title>
<source/>Science
          <year>2009</year>
<volume>324</volume>
<issue>5929</issue>
<fpage>929</fpage>
<lpage>930</lpage>
<pub-id pub-id-type="pmid">19372393</pub-id>
</element-citation>
</ref>
<ref id="R135">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Szulwach</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
<article-title>5-hmC–mediated epigenetic dynamics during postnatal neurodevelopment and aging.</article-title>
<source/>Nat Neurosci
          <year>2011</year>
<volume>14</volume>
<issue>12</issue>
<fpage>1607</fpage>
<lpage>1616</lpage>
<pub-id pub-id-type="pmid">22037496</pub-id>
</element-citation>
</ref>
<ref id="R136">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Mellén</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ayata</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Dewell</surname>
<given-names>S</given-names>
</name>
<etal></etal>
<article-title>MeCP2 Binds to 5hmC Enriched within Active Genes and Accessible Chromatin in the Nervous System.</article-title>
<source/>Cell
          <year>2012</year>
<volume>151</volume>
<issue>7</issue>
<fpage>1417</fpage>
<lpage>1430</lpage>
<pub-id pub-id-type="pmid">23260135</pub-id>
</element-citation>
</ref>
<ref id="R137">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Rivenbark</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Stolzenburg</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Beltran</surname>
<given-names>AS</given-names>
</name>
<etal></etal>
<article-title>Epigenetic reprogramming of cancer cells via targeted DNA methylation.</article-title>
<source/>Epigenetics
          <year>2014</year>
<volume>7</volume>
<issue>4</issue>
<fpage>350</fpage>
<lpage>360</lpage>
</element-citation>
</ref>
<ref id="R138">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Siddique</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Nunna</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rajavelu</surname>
<given-names>A</given-names>
</name>
<etal></etal>
<article-title>Targeted Methylation and Gene Silencing of VEGF-A in Human Cells by Using a Designed Dnmt3a–Dnmt3L Single-Chain Fusion Protein with Increased DNA Methylation Activity.</article-title>
<source/>J Mol Biol
          <year>2013</year>
<volume>425</volume>
<issue>3</issue>
<fpage>479</fpage>
<lpage>491</lpage>
<pub-id pub-id-type="pmid">23220192</pub-id>
</element-citation>
</ref>
<ref id="R139">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Vojta</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dobrinić</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Tadić</surname>
<given-names>V</given-names>
</name>
<etal></etal>
<article-title>Repurposing the CRISPR-Cas9 system for targeted DNA methylation.</article-title>
<source/>Nucleic Acids Res
          <year>2016</year>
<volume>44</volume>
<issue>12</issue>
<fpage>5615</fpage>
<lpage>5628</lpage>
<pub-id pub-id-type="pmid">26969735</pub-id>
</element-citation>
</ref>
<ref id="R140">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>McDonald</surname>
<given-names>JI</given-names>
</name>
<name>
<surname>Celik</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Rois</surname>
<given-names>LE</given-names>
</name>
<etal></etal>
<article-title>Reprogrammable CRISPR/Cas9-based system for inducing site-specific DNA methylation.</article-title>
<source/>Biol Open
          <year>2016</year>
<volume>5</volume>
<issue>6</issue>
<fpage>866</fpage>
<lpage>874</lpage>
<pub-id pub-id-type="pmid">27170255</pub-id>
</element-citation>
</ref>
<ref id="R141">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Maeder</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Angstman</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>ME</given-names>
</name>
<etal></etal>
<article-title>Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins.</article-title>
<source/>Nat Biotech
          <year>2013</year>
<volume>31</volume>
<issue>12</issue>
<fpage>1137</fpage>
<lpage>1142</lpage>
</element-citation>
</ref>
<ref id="R142">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Lu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>L</given-names>
</name>
<etal></etal>
<article-title>Role of Tet proteins in enhancer activity and telomere elongation.</article-title>
<source/>Genes Dev
          <year>2014</year>
<volume>28</volume>
<issue>19</issue>
<fpage>2103</fpage>
<lpage>2119</lpage>
<pub-id pub-id-type="pmid">25223896</pub-id>
</element-citation>
</ref>
<ref id="R143">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Liu</surname>
<given-names>XS</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>X</given-names>
</name>
<etal></etal>
<article-title>Editing DNA Methylation in the Mammalian Genome.</article-title>
<source/>Cell
          <year>2016</year>
<volume>167</volume>
<issue>1</issue>
<fpage>233</fpage>
<lpage>247</lpage>
<pub-id pub-id-type="pmid">27662091</pub-id>
</element-citation>
</ref>
<ref id="R144">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Josselyn</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Köhler</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Frankland</surname>
<given-names>PW</given-names>
</name>
<etal></etal>
<article-title>Finding the engram.</article-title>
<source/>Nat Rev Neurosci
          <year>2015</year>
<volume>16</volume>
<issue>9</issue>
<fpage>521</fpage>
<lpage>534</lpage>
<pub-id pub-id-type="pmid">26289572</pub-id>
</element-citation>
</ref>
<ref id="R145">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Klein</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Mazutis</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Akartuna</surname>
<given-names>I</given-names>
</name>
<etal></etal>
<article-title>Droplet Barcoding for Single-Cell Transcriptomics Applied to Embryonic Stem Cells.</article-title>
<source/>Cell
          <year>2015</year>
<volume>161</volume>
<issue>5</issue>
<fpage>1187</fpage>
<lpage>1201</lpage>
<pub-id pub-id-type="pmid">26000487</pub-id>
</element-citation>
</ref>
<ref id="R146">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Macosko</surname>
<given-names>EZ</given-names>
</name>
<name>
<surname>Basu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Satija</surname>
<given-names>R</given-names>
</name>
<etal></etal>
<article-title>Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets.</article-title>
<source/>Cell
          <year>2015</year>
<volume>161</volume>
<issue>5</issue>
<fpage>1202</fpage>
<lpage>1214</lpage>
<pub-id pub-id-type="pmid">26000488</pub-id>
</element-citation>
</ref>
<ref id="R147">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Rotem</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ram</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Shoresh</surname>
<given-names>N</given-names>
</name>
<etal></etal>
<article-title>Single-cell ChIP-seq reveals cell subpopulations defined by chromatin state.</article-title>
<source/>Nat Biotechnol
          <year>2015</year>
<volume>33</volume>
<issue>11</issue>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="pmid">25574611</pub-id>
</element-citation>
</ref>
<ref id="R148">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Buenrostro</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Litzenburger</surname>
<given-names>UM</given-names>
</name>
<etal></etal>
<article-title>Single-cell chromatin accessibility reveals principles of regulatory variation.</article-title>
<source/>Nature
          <year>2015</year>
<volume>523</volume>
<issue>7561</issue>
<fpage>486</fpage>
<lpage>490</lpage>
<pub-id pub-id-type="pmid">26083756</pub-id>
</element-citation>
</ref>
<ref id="R149">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>De Rubeis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Goldberg</surname>
<given-names>AP</given-names>
</name>
<etal></etal>
<article-title>Synaptic, transcriptional and chromatin genes disrupted in autism.</article-title>
<source/>Nature
          <year>2014</year>
<volume>515</volume>
<issue>7526</issue>
<fpage>209</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="pmid">25363760</pub-id>
</element-citation>
</ref>
<ref id="R150">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Williams</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Fricano-Kugler</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Getz</surname>
<given-names>SA</given-names>
</name>
<etal></etal>
<article-title>A Retroviral CRISPR-Cas9 System for Cellular Autism-Associated Phenotype Discovery in Developing Neurons.</article-title>
<source/>Sci Rep
          <year>2016</year>
<volume>6</volume>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="pmid">28442746</pub-id>
</element-citation>
</ref>
<ref id="R151">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Mabb</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>King</surname>
<given-names>IF</given-names>
</name>
<etal></etal>
<article-title>Topoisomerase 1 Regulates Gene Expression in Neurons through Cleavage Complex-Dependent and -Independent Mechanisms.</article-title>
<source/>PLoS ONE
          <year>2016</year>
<volume>11</volume>
<issue>5</issue>
<fpage>e0156439-18</fpage>
<pub-id pub-id-type="pmid">27231886</pub-id>
</element-citation>
</ref>
<ref id="R152">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Wei</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>M</given-names>
</name>
<etal></etal>
<article-title>α/β-Hydrolase domain-containing 6 (ABHD6) negatively regulates the surface delivery and synaptic function of AMPA receptors.</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2016</year>
<volume>113</volume>
<issue>19</issue>
<fpage>E2695-704</fpage>
<pub-id pub-id-type="pmid">27114538</pub-id>
</element-citation>
</ref>
<ref id="R153">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Maharjan</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Künzli</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Buthey</surname>
<given-names>K</given-names>
</name>
<etal></etal>
<article-title>C9ORF72 Regulates Stress Granule Formation and Its Deficiency Impairs Stress Granule Assembly, Hypersensitizing Cells to Stress.</article-title>
<source/>Mol Neurobiol
          <year>2016</year>
<fpage>1</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="pmid">25394384</pub-id>
</element-citation>
</ref>
<ref id="R154">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Platt</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
<article-title>CRISPR-Cas9 knockin mice for genome editing and cancer modeling.</article-title>
<source/>Cell
          <year>2014</year>
<volume>159</volume>
<issue>2</issue>
<fpage>440</fpage>
<lpage>455</lpage>
<pub-id pub-id-type="pmid">25263330</pub-id>
</element-citation>
</ref>
<ref id="R155">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Park</surname>
<given-names>C-Y</given-names>
</name>
<name>
<surname>Halevy</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>DR</given-names>
</name>
<etal></etal>
<article-title>Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons.</article-title>
<source/>Cell Rep
          <year>2015</year>
<volume>13</volume>
<issue>2</issue>
<fpage>234</fpage>
<lpage>241</lpage>
<pub-id pub-id-type="pmid">26440889</pub-id>
</element-citation>
</ref>
<ref id="R156">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Zhou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>K</given-names>
</name>
<etal></etal>
<article-title>Generation of Human Embryonic Stem Cell Line Expressing zsGreen in Cholinergic Neurons Using CRISPR/Cas9 System.</article-title>
<source/>Neurochem Res
          <year>2016</year>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="pmid">26830288</pub-id>
</element-citation>
</ref>
<ref id="R157">
<element-citation publication-format="print" publication-type="journal">
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W</given-names>
</name>
<etal></etal>
<article-title>CRISPR/Cas9 facilitates investigation of neural circuit disease using human iPSCs: mechanism of epilepsy caused by an SCN1A loss-of-function mutation.</article-title>
<source/>Transl Psychiatry
          <year>2016</year>
<volume>6</volume>
<issue>1</issue>
<fpage>e703</fpage>
<lpage>e709</lpage>
<pub-id pub-id-type="pmid">26731440</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<table-wrap id="T1" orientation="portrait" position="float">
<label>Table 1</label>
<caption>
<title>Summary of genes targeted by diverse CRISPR/Cas9 strategies in mammalian neurons.</title>
</caption>
<table frame="hsides" rules="groups">
<thead align="left">
<tr>
<td colspan="1" rowspan="1">
<bold>CRISPR manipulation</bold>
</td>
<td colspan="1" rowspan="1">
<bold>Gene targets</bold>
</td>
<td colspan="1" rowspan="1">
<bold>References</bold>
</td>
</tr>
</thead>
<tbody align="left">
<tr>
<td colspan="1" rowspan="1">Conditional knockout in neurons</td>
<td colspan="1" rowspan="1"><italic>Abhd6</italic>, <italic>Dnmt1</italic>, <italic>Dnmt3a</italic>, <italic>Dnmt3b</italic>, <italic>GRIA2</italic>, <italic>Grin1</italic>, <italic>GRIN1</italic>, <italic>Katnal2</italic>, <italic>Mecp2</italic>, <italic>Rbfox3</italic>, <italic>Top1</italic>, <italic>3110043O21Rik</italic></td>
<td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="R57">57</xref>-<xref ref-type="bibr" rid="R59">59</xref>,<xref ref-type="bibr" rid="R150">150</xref>-<xref ref-type="bibr" rid="R154">154</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Knockin of variant to neuronal gene</td>
<td colspan="1" rowspan="1"><italic>APP</italic>, <italic>FMR1</italic>, <italic>PSEN1</italic></td>
<td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="R47">47</xref>,<xref ref-type="bibr" rid="R155">155</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Deletion of <italic>cis</italic>-regulatory
element</td>
<td colspan="1" rowspan="1">
<italic>Prdm1</italic>
</td>
<td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="R64">64</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Activation of proximal and distal enhancers</td>
<td colspan="1" rowspan="1">
<italic>Grin2c</italic>
</td>
<td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="R16">16</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Repression of distal enhancers</td>
<td colspan="1" rowspan="1">
<italic>Fos</italic>
</td>
<td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="R112">112</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Knockin of small epitope tag for visualization</td>
<td colspan="1" rowspan="1"><italic>Actb</italic>, <italic>Arc</italic>, <italic>Camk2a</italic>, <italic>Cacna1c</italic>, <italic>CHAT</italic>, <italic>Dcx</italic>, <italic>Fmrp</italic>, <italic>GAD67</italic>, <italic>Mecp2</italic>, <italic>Prkca</italic>, <italic>Rab11a</italic>, <italic>Ywhae</italic></td>
<td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="R97">97</xref>,<xref ref-type="bibr" rid="R156">156</xref>,<xref ref-type="bibr" rid="R157">157</xref>]</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F1" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p><bold><italic>Cis</italic>-regulatory elements and the control of gene transcription.</bold> A] Linear diagram of a hypothetical transcribed gene [green arrow] and its promoter [Prom] flanked by two insulator elements [Ins] and two enhancers [Enh]. B] Binding of the chromatin architectural factor CTCF to insulator elements traps the enhancer in a loop away from the gene promoter, inhibiting transcription [red arrow]. C] Following developmental methylation [Me] of insulator elements, which blocks CTCF binding, the enhancer loops over to interact with the promoter, promoting transcription. The active enhancer is marked by H3K27 acetylation [Ac]. D] Upon activity-induced recruitment of transcriptional co-activators, a shadow enhancer is recruited to the gene promoter, further promoting transcription.</p>
</caption>
<graphic xlink:href="yjbm_89_4_457_g01"></graphic>
</fig>
<fig id="F2" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<p>Number of publications on PubMed per year with CRISPR/Cas9, ZFN, or TALEN in their titles or abstracts. These numbers exclude all review publications.</p>
</caption>
<graphic xlink:href="yjbm_89_4_457_g02"></graphic>
</fig>
<fig id="F3" orientation="portrait" position="float">
<label>Figure 3</label>
<caption>
<p><bold>Applications of CRISPR/Cas9 in neurons.</bold> A] Substitution of <italic>cis</italic>-regulatory sequences. B] Introduction of small epitope tag to C-terminus of neuronal gene. C] Repression of <italic>cis</italic>-regulatory element. D] Activation of <italic>cis</italic>-regulatory element by editing its epigenomic landscape. Histone proteins denoted in gray, histone methylation in pink, and histone acetylation in yellow.</p>
</caption>
<graphic xlink:href="yjbm_89_4_457_g03"></graphic>
</fig>
</floats-group>
</article>
</pmc-articleset>